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Extracellular signal-regulated kinase (ERK) signaling is required for function of the 
hypothalamic-pituitary-gonadal axis. This axis is regulated by interconnected 
hormonal feedback loops, permitting reproduction. Gonadotropin releasing hormone 
(GnRH) is secreted by the hypothalamus to act on the pituitary, resulting in 
gonadotropin secretion. The gonadotropins, luteinizing hormone (LH) and follicle 
stimulating hormone (FSH) are produced and secreted by pituitary gonadotropes, and 
act on the gonads, promoting steroidogenesis and gametogenesis. This dissertation 
focuses on two isoforms of ERK, ERK 1 and ERK 2. Although they do appear to have 
some redundant functions, ERK 1 is not able to compensate for loss of ERK 2. ERK1 
null mice are viable and fertile, whereas loss of ERK2 is embryonic lethal. Therefore, 
ERK 2 has to be knocked out in a tissue or time dependent manner. For the studies 
included here, we utilize a mouse model of GnRHR associated ERK loss. This model 
allows us to investigate the role of ERK in pituitary gonadotropin production and 
secretion. ERK loss significantly reduced gonadotropin production, and this model 
allowed us to characterize the effects of hypogonadotropism as animals aged. We 
followed those studies with an investigation into GnRHR localization and function in 
the murine placenta, and the effects of ERK loss on placentation, gestation, and 
parturition. These experiments revealed abnormal histology and vascularization, 
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prolonged gestation and dystocia, and absolute fetal mortality. Finally, we utilized 
unbiased screening techniques (RNA sequencing) to identify novel targets of GnRH 
signaling downstream of the ERK cascade. This revealed a bile acid receptor, TGR5, 
which has a functional role in gonadotropin production in the pituitary. Female TGR5 
knockout are subfertile, with a marked delay in the onset of puberty. The studies in 
this dissertation describe the role of ERK in multiple aspects of the HPG axis. All of 
the studies have clinical implications, either in the understanding and treatment of 
idiopathic hypogonadotropic hypogonadism (IHH) or in understanding links between 
puberty, nutrition, metabolism and fertility. 
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CHAPTER 1 
Literature Review 
 
Introduction 
The hypothalamic-pituitary-gonadal (HPG) axis controls reproduction via a series of 
hormones regulating gonadal function through interconnected feedback loops. 
Secretion of hypothalamic-derived gonadotropin-releasing hormone (GnRH) 
integrates inputs from higher brain centers to coordinate the activity of the pituitary 
gonadotrope and the biosynthesis and secretion of the gonadotropins which ultimately 
regulate gonadal function.
1
 Failure of GnRH to serve as the central integrator of this 
system has been associated with idiopathic hypogonadotropic-hypogonadism (IHH) 
and clinical infertility, while pharmacological application of GnRH analogs and 
gonadotropins has important implications of the treatment of such infertility.
2
 IHH is 
relatively rare, with a prevalence of 1 in 10,000 men.
3
 However, it has been estimated 
that up to 16 percent of couples suffer from infertility, causing huge economic and 
social implications.
4–6
 Further, the GnRH-GnRH receptor (GnRHR) system has been 
characterized in several types of cancer and may offer therapeutic possibilities in their 
treatment. Given the central role of GnRH action in the control of fertility, it is of 
paramount importance to understand the molecular basis of control of GnRH action in 
the pituitary gonadotrope, including new and novel alternate ways to modulate GnRH 
action and gonadotropin secretion. The goal of this review is to summarize established 
knowledge regarding the HPG axis and to discuss several new findings in this field 
focusing on novel regulators of GnRH action.  
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(A portion of this Chapter has been accepted as an invited review for publication in 
Seminars in Reproductive Medicine in a manuscript entitled “Novel insights into 
gonadotropin-releasing hormone action in the pituitary gland”.7  
 
Development and function of the pituitary in the hypothalamic-pituitary-gonadal 
axis 
The hypothalamic-pituitary-gonadal (HPG) endocrine axis regulates 
reproductive function. Hypothalamic neurons produce the decapeptide gonadotropin-
releasing hormone (GnRH), which is released by nerve terminals at the median 
eminence and travels through the hypophyseal portal vasculature to the anterior 
pituitary.
8
 The anterior pituitary (adenohypophysis) develops in conjunction with the 
intermediate and posterior pituitary (neurohypophysis), to form the functional pituitary 
unit. As a discrete endocrine organ, the anterior pituitary serves to control numerous 
physiological functions such as control of growth, stress, basal metabolism, lactation 
and reproduction. This is accomplished through the development of five endocrine cell 
lineages (gonadotropes, somatotropes, thyrotropes, lactotropes and corticotropes) that 
collectively function to control systemic homeostasis. Interestingly, these tissues 
derive from different embryonic origins; the neurohypophysis from neural ectoderm, 
and the intermediate and anterior pituitary from oral ectoderm.
9
 Rathke’s pouch, the 
embryonic origin of the anterior and intermediate pituitary, begins to form at 
embryonic day (e)7.5 in the mouse.
10
 There is a rudimentary pouch by e8.5, and the 
pouch is fully established at e12.5.
11–13
 This anatomic feature was first described in 
1830, by H. Rathke, and was further investigated by E. Frazer in 1911.
14,15
 Originally, 
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Rathke’s pouch was noted to be derived from both brain and gut tissue. Several of 
these researchers described the neuro- and adenohypophysis developing separately and 
fusing as the embryo develops.
9,16
 Further differentiation of specific cell lineages and 
expansion of the gland continues throughout gestation, regulated by factors such as 
bone morphogenic protein 4 (BMP4), fibroblast growth factor (FGF), sonic hedgehog, 
Wnt, BMP2, and others.
17,18
 Other transcription factors regulate the development of 
specific cell lineages. For pituitary gonadotropes, these include expression of NR5A1, 
Lhx3 and Lhx4, Egr-1, Pitx1, and several others.
19–22
 Gonadotropes, along with 
lactotropes, somatotropes, thyrotropes, and corticotropes make up the cell types within 
the anterior pituitary.
23
  
About 10-15 percent of cells in the anterior pituitary are gonadotropes.
24,25
 
These cells can be identified by the expression of 4 genes: the two unique 
gonadotropin subunits, luteinizing hormone β (LHβ) and follicle stimulating hormone 
β (FSHβ), their common glycoprotein hormone subunit (αGSU), and the GnRHR.26 
This specific signature is utilized in subsequent chapters of this dissertation to help 
define effects of various genetic interventions and treatments used in these studies. 
GnRHR, a G-protein coupled receptor (GPCR) is expressed on the surface of the 
gonadotrope cell lineage in the anterior pituitary.
27
 The receptor couples with GnRH 
released from the hypothalamus, in a highly evolutionarily conserved pairing. 
28
  
 
The GnRHR and GnRH signaling 
As mentioned previously, GnRHR is a rhodopsin-like GPCR with high 
specificity and affinity for its ligand, GnRH.
29,30
 Like most GPCRs, GnRHR has 7 
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transmembrane domains, with three intracellular and three extracellular loops. 
Broadly, there are three groups of GnRHRs, with only the first two being found in 
mammals.
31,32
 GnRHR I binds with GnRH I, and is the main regulator of the HPG 
axis. GnRHR II binds to GnRH II, but binds very poorly to GnRH I. Humans 
functionally only express GnRHR I; GnRHR II is not functional as it contains a 
frameshift mutation, leading to a stop codon.
31–33
 Unlike other GPCRs, GnRHR lacks 
an intracellular carboxyl terminal tail.
1,32,34
 These tails play a role in organizing 
receptor localization and desensitization following ligand occupancy. In other GPCRs, 
phosphorylation of the carboxyl terminal tail is involved in membrane internalization 
and desensitization of GPCRs; however, given the consipcious lack of a c-terminal 
tails, the GnRHR has been described as resistant to desensitization and 
downregulation.
35–37
 Additionally, only one percent of GnRHRs are found on the cell 
surface, but addition of a C-terminal tail increases this percentage between 10 and 50 
fold suggesting this portion of GPCRs coordinates trafficking and subcellular 
localization.
38,39
 The majority of GnRHRs are found in the ER. 
39,40
 Those receptors 
that are found on the cell surface are found exclusively in the membrane rafts. 
Membrane rafts are small domains within the plasma membrane that are enriched in 
cholesterol and sphingolipids.
41
 In normal conditions, the presence of GnRHR in the 
raft compartment is exclusive and constitutive. Further disruption of raft association 
uncouples GnRHR to normal cell signaling suggesting this localization is critical for 
GnRHR function. GnRHRs can be relocated to non-raft compartments of the plasma 
membrane if a C-terminal tail from a non-raft associated GPCR is fused to the 
GnRHR.
42
 GnRHR associates with many signaling complexes in the membrane raft, 
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such as Gαq, c-Raf kinase and the mitogen-activated protein kinase (MAPK) ERK1/2, 
confirming its involvement in this signaling cascade.
43
 GnRH/GnRHR involvement in 
MAPK signaling is described below. 
GnRH binds to the GnRHR, activating the heterotrimeric G protein Gαq which 
activates phospholipase Cβ (PLC).38,44,45 This leads to accumulation of PLC-derived 
diffusible second messengers inositol 1,4,5-trisphosphate (IP3) and diacylglycerol 
(DAG).
46
 These signaling intermediates facilitate calcium (Ca
2+
) release from 
endoplasmic reticulum and activation of protein kinase C (PKC), respectively, and 
PKC activation and membrane depolarization leads to activation of voltage-dependent 
L-type Ca
2+
 channels leading to influx of extracellular calcium.
47
 Release of internal 
calcium stores and calcium derived from extracellular sources via L-type Ca
2+
channels 
along with PKC activation activate key MAPK pathways necessary for the 
downstream effects of GnRH. These include the biosynthesis of gonadotropin subunits 
and modulators of MAPK signaling such as dual specificity phosphatases thought to 
regulate the activation kinetics (magnitude and duration) of MAPKs.
48–50
  
MAPK signaling in the HPG axis 
MAPKs are a large family of serine-threonine kinases that play important roles 
in the regulation of cell proliferation, differentiation, migration and apoptosis 
depending upon developmental and physiological context. They participate in well-
established phosphorylation cascades, starting with MAPKKK, which activate 
MAPKK, and finally phosphorylation of MAPK. The terminal kinases of the four 
main signaling cascades include extracellular signal-regulated kinase (ERK1/2), c-Jun 
N-terminal kinase (JNK), big MAPK (BMK), and the p-38 stress-activated protein 
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kinase.
51–54
 Our lab, and research reported within this dissertation, focuses on ERK1/2 
signaling. The canonical ERK signaling pathways is comprised of cRaf protein kinase, 
which phosphorylates MAP-ERK (MEK) kinases 1 and 2, which phosphorylates 
ERK1/2 on threonine and tyrosine residues to induce activation of these kinases.
55
 
After phosphorylation by MEKs, ERKs translocate from the cytoplasm to the nucleus, 
where they phosphorylate and activate transcription factors such as CREB, c-Fos, c-
Jun, Elk1, and Egr1.
56
 Despite a wealth of data supporting this canonical cascade, 
work in our lab has shown that other MAPKKKs may be involved in ERK1/2 
activation, as cRaf kinase phosphorylation is not required for ERK activation by 
GnRH.
57
 Thus, a definitive understanding of this signaling pathway is not yet 
complete. However, an intact MAPK cascade is necessary for proper function of the 
gonadotropes and gonadotropin release.
26,58
 
GnRH stimulation of pituitary gonadotropes is required for the biosynthesis of 
LH and FSH. These two glycoprotein hormones are heterodimers composed of αGSU 
and their respective β-subunits; the β subunits are requisite for the specific biological 
actions of the two gonadotropins. LH and FSH act upon the gonads to regulate 
gametogenesis and steroidogenesis and ultimately ovulation.
27
 Specific evidence for 
GnRH requirement comes from studies of the hypogonadal (HPG) mouse, a model 
with a naturally occurring loss-of-function mutation in the GnRH gene. The HPG 
mouse is infertile, with arrested germ cell development, and lacks GnRH, LH and 
FSH.
59
 Restoration of the GnRH gene restored gonadotrope cell function and fertility 
to these mice.
60
 This mouse has been a commonly used model system to understand 
the role of specific aspects of the HPG axis.
61,62
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GnRH and gonadotropin pulsatility 
LH is secreted by the pituitary gonadotropes in a pulsatile fashion coincident 
with pulsatile secretion of GnRH.
63
 A GnRH surge, and subsequent LH surge is 
required for ovulation.
64
 Several labs have shown the importance of the signaling 
cascades initiated by GnRH, including ERK, on LH production and secretion. 
Important factors include CREB binding protein (CBP), ERK, FOXP3, Pitx1, and 
Egr1
65–69
  
Another important signal in controlling gonadotropin secretion stems from 
steroid hormones and the feedback loops they participate in. Androgens inhibit LHβ 
transcription, while estradiol promotes LHβ transcription, the latter a likely function of 
estradiol’s ability to upregulate the GnRHR within the gonadotrope at times important 
to preparation for ovulation.
70,71
 GnRH stimulation has a direct link to LH release; 
pulsatile stimulation of GnRH from the hypothalamus in pituitary causes a LH pulse 
event in sheep.
72
 Multiple other factors contribute to this relationship, such as post-
partum interval and estradiol concentration.
73
 Fasting also decreased LH pulsatility, 
but leptin administration restored normal LH secretion, indicating a link between 
metabolic status, energy balance, and gonadotropins.
74
 Other factors that alter GnRH 
and LH secretion include endogenous opioid concentrations and photoperiod.
75
 
Like LH, FSH is impacted by GnRH pulse frequency, transcription factor 
expression, such as SMAD, Lhx3, Pitx1 and 2, and steroid hormone concentration.
76–
79
 However, it is also regulated by other hormones, such as inhibin, activin, and 
follistatin. Inhibin and activin are secreted locally in the pituitary, and act in both 
paracrine and autocrine fashions. They colocalize in granules with LH and FSH, and 
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are secreted simultaneously.
80
 Inhibin and activin are also secreted from the gonads, 
regulating the gonadotropes through systemic circulation as well as locally.
81
 Thus, 
while LH and FSH share a dependence on GnRH stimulation of the gonadotrope, FSH 
clearly requires additional integration by secreted factors that do not control LH 
biosynthesis and secretion. Studies in this dissertation focus on novel factors 
controlling the secretion of gonadotropins.  
For both gonadotropins, GnRH pulse frequency is a significant regulator of 
production and release. Early studies in primates by Knobil and colleagues revealed 
that continuous exposure to GnRH resulted in diminished gonadotropin synthesis and 
secretion while pulsatile administration elevated production and secretion of 
gonadotropins. Later studies by the Kaiser group and others more fully appreciated the 
impact of slow versus rapid GnRH pulses and the impact of variable interpulse 
interval on gonadotropin subunit gene expression; consistent with pulse frequencies 
observed during the menstrual and estrous cycles, slow GnRH pulse frequency 
favored FSHβ expression while more rapid pulses favored LHβ expression.82–87 More 
recently, GnRH-induced signals derived from such intermediates as Protein kinase A 
(PKA), cAMP response element binding protein (CREB), inducible cAMP early 
repression (ICER), PI3K and PI4K were found to greatly impact how differences in 
GnRH pulse frequency affected gonadotropin synthesis and secretion.
88
 These 
signaling intermediates are activated by GnRH stimulation at variable pulse frequency, 
and can be influenced by other hormones such as inhibin, activin, and steroid 
hormones which helps to produce and control gonadotropin production and 
secretion.
89
 The signaling relationship between PKA, CREB and ICER was 
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particularly intriguing since PKA activates CREB and ICER is a CREB repressor. 
Thompson and colleagues demonstrated that within the GnRH signaling network, slow 
GnRH pulsatility favored FSHβ expression and specific inhibition of PKA catalytic 
activity decreased GnRH-induced CREB phosphorylation, and subsequent FSHβ 
transcription.
90
 GnRH stimulation also increased ICER levels in gonadotropes; 
however, this increase was blocked with PKC and MEKI/II inhibitors suggesting 
GnRH-induced ICER levels were ERK dependent.
88
 Inhibition of PKA and CamKII 
did not inhibit ICER induction.
88
  
To determine a potential role of ICER on the impact of PKA/CREB, studies 
were conducted in LβT2 cells using variable pulse frequencies. Rapid pulses stimulate 
Lhb expression, and low pulse frequency known to regulate Fshb expression through 
CREB activation. ICER accumulation in gonadotropes was higher with high GnRH 
pulse frequency compared to low pulse frequency, and this response was blunted with 
MEKI/II-ERK pathway inhibition. It may be that low frequency GnRH pulses 
preferentially induce PKA activation and CREB phosphorylation, leading to 
preferential FSH biosynthesis and secretion.
90
 Rapid GnRH pulse frequency 
preferentially increases LHβ and ICER accumulation, effectively blocking a role for 
CREB on FSHβ under these conditions.  
 
Recent advances in our understanding of gonadotrope biology and GnRH action 
Due to the vital and dynamic role of the anterior pituitary-derived 
gonadotropins in controlling the reproductive axis, understanding gonadotrope 
regulation and function by GnRH and other factors are areas of active research. This is 
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an enormous field of study that has been reviewed extensively by many including our 
lab.  
 Clinical conditions such as IHH in humans may best characterize the absolute 
requirement for GnRH and GnRH signaling in the support of fertility. This condition 
is often caused by a failure in GnRH neuron migration from the olfactory placode to 
the hypothalamus, and when combined with anosmia, is referred to as Kallmann’s 
syndrome.
91
 This syndrome has been associated with multiple genetic mutations 
including those in FGF8, FGFR1, KAL1, SEMA-3A, GNRHR, PROK2, PROKR2, and 
KISSR, among others.
2,92
 Failure of the GnRH neuronal migration leads to a lack of 
GnRH stimuli to the gonadotrope and subsequent failure of the reproductive axis. 
These patients suffer from infertility and often are insensitive to GnRH stimulation.
93
 
However, the variation in phenotypes can even occur between siblings with the same 
genetic mutation.
94
 IHH patients who are treated for fertility often have variable 
responses to exogenous GnRH and gonadotropin treatment.
95–100
 Phenotypes involved 
include everything from infertility to weight gain, to miscarriage, deafness and 
anosmia.
91,101,102
 With multiple known mutations in GnRH and GnRHR that result in 
IHH, understanding the mechanisms and pathways of GnRH related signaling in 
multiple tissues can help lead to understanding and treatment of this condition.
95,101,103
 
Appropriately, GnRH and its agonists have come to play important roles in both 
fertility treatments and contraceptive regimens.
104,105
 
In addition to the role of GnRH/GnRHR in controlling fertility, more recent 
studies provide evidence that GnRH and GnRHR are important outside of the HPG 
axis. Tran et al recently explored local effects of FoxL2 deletion in the pituitary and 
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the testes, using a GnRHR associated Cre line.
76
 GnRHR is alsoexpressed in the 
ovary, oviduct and lymphocytes.
106–108
 In addition, GnRHR has recently been 
characterized in the placenta of multiple species, including humans, mice, and 
dogs.
109–111
 Knowledge of these extra-pituitary sites of GnRHR expression have 
important implications for my dissertation research and will be examined in 
subsequent chapters of this thesis. GnRH and GnRHR are associated with multiple 
types of cancer, including prostate, ovarian cancer, benign prostate hyperplasia, 
adrenal adenoma, leiomyoma, nasopharyngeal carcinoma, and gastric cancer. GnRH 
and its receptor may have roles in treatment, metastasis, prognosis and other aspects of 
cancer biology, both within and outside of the HPG axis.
112–118
 With these novel and 
emerging functions of GnRH, understanding its signaling and function is of paramount 
importance.  
 
GnRHR and spatially restricted Ca
2+
 signaling 
As described above, GnRH-induced calcium signaling in gonadotropes has 
long been established as a potent modulator of gonadotrope function and gonadotropin 
secretion.
119–121
 Calcium flux induced by GnRH signaling induces secretion of 
gonadotropins and activation of MAPK cascades, which lead to LH and FSHβ subunit 
gene and GnRHR transcription via extracellular signal–regulated kinases (ERK) and 
c-Jun N-terminal kinases (JNK), as well as changes in the actin cytoskeleton. These 
Ca
2+
 responses are particularly integral to ERK activation and subsequent 
gonadotropin release.
120,122
 GnRH-induced ERK activity is required for fertility in 
female mice, and genetic loss of both ERK isoforms conditionally in the gonadotrope 
 26 
leads to an anovulatory infertility in female mice (a focus on my dissertation 
research).
65
 Two separate pools of calcium appear to govern the ability of GnRH to 
discriminate activity of MAPK signaling pathways; GnRH-induced ERK activation is 
regulated by calcium influx through L-type Ca
2+
 channels, while activation of JNK 
isoforms appears to require a much larger Ca
2+
 flux from intracellular stores.
120
 
Interestingly, these calcium spikes are not all equivalent but appear to correlate with 
the magnitude and duration of GnRH input to the gonadotrope. Low levels of GnRH 
cause small, irregular Ca
2+ 
transients, but larger amplitude GnRH pulses cause larger 
changes in Ca
2+
 signaling.
121
 Variation in frequency and amplitude of these transients 
help differentiate signals for FSH and LH production. For example, LH biosynthesis is 
tightly regulated by these Ca
2+
 signals, with an intense peak of production at the 
GnRH/LH surge, inciting ovulation. In contrast, FSH is produced at a more constant, 
basal level, without the supraphysiologic drive of a large secretory event.  
The hypothesis that local membrane-associated Ca
2+
 transients were necessary 
for GnRH-induced ERK activity was originally substantiated by pharmacological 
studies that disrupted the L-type channel; however, these studies did not provide 
important evidence that new elegant imaging strategies can provide.
48
 Understanding 
how calcium transients are controlled at local, spatially restricted levels within the cell 
would potentially inform pharmacological interventions that would be useful in the 
control of fertility. Using novel total internal reflection fluorescence (TIRF) 
microscopy, Dang and colleagues were able to visualize Ca
2+
 influx via L-type Ca
2+
 
channels following activation of GnRHR signal transduction. Recall that TIRF 
microscopy takes advantage of strategies of imaging of fluorescent activities directly 
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at the cell surface offering the opportunity to examine spatially restricted fluorescent 
signals rather than Ca
2+
 transients that occur more deeply within the cytosol. The 
spatially restricted Ca
2+
 flux was appropriately termed calcium “sparklets” that 
occurred at the surface of the gonadotrope when stimulated with GnRH.
120
 These 
sparklets were recapitulated with an L-type Ca
2+
 channel agonist FPL 64176, which 
also resulted in ERK activation reminiscent of GnRH stimulation. If these L-type Ca
2+
 
channels were blocked using nicardipine, or the cytoskeleton was stabilized 
pharmacologically, the sparklets and subsequent ERK activation was prevented, 
indicating spatially restricted calcium influx through L-type channels is a key calcium 
signal induced by GnRHR activation leading to ERK activation.
120
 ERK activation is 
known to occur through direct PKC activation to mimic GnRH action, and in 
accordance with that, a PKC agonist activated calcium sparklets in a manner 
consistent with GnRH or FPL 64176. Interestingly, GnRH-induced cytoskeletal actin 
reorganization also appears to be required for the induction of spatially restricted 
calcium sparklets and ERK activation.
120
 Pretreating cells with an actin stabilizer 
(jasplakinolide) effectively preventing actin reorganization followed by treatment with 
GnRH inhibited calcium sparklets and ERK pathway activation. Both intra-and 
extracellular calcium stores play key roles in gonadotrope function. 
 
GnRH action and the actin cytoskeleton 
An important role for GnRH-induced actin reorganization and LH secretion 
was recently described by our group.
123
 With GnRH stimulation, the actin-associated 
protein cortactin migrates to the leading edge of gonadotropes, localizing with actin 
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and actin-related protein 3 (Arp3), an effect mediated by phosphorylation of tyrosine 
kinases.
123
 Blocking either cortactin or ARP resulted in the loss of actin-dependent 
lamellipodia and membrane ruffles, as well as gonadotropin secretion. The actin 
remodeling necessary for response to GnRH is dependent on cortactin re-localization 
within the cytoskeleton, as is gonadotropin secretion.
123,124
  
Recent studies by Edwards and colleagues extended our understanding of the 
mechanisms of the role of actin cytoskeleton in GnRH signaling via L-type Ca2+ 
channels and ERK activation.
125
 Dynamin is a membrane-associated GTPase that is 
involved in membrane constriction, vesiculation and cell wall formation.
126
 Disrupting 
dynamin signaling in gonadotropes has long been known to disrupt GnRH signaling to 
the ERK pathway
127–129
, however, the mechanistic basis for this has not been fully 
appreciated. By creating a dynamin-GFP fusion protein and expressing it in clonal 
gonadotrope cells (αT3-1 cells), Edwards and colleagues were able to visualize the 
distribution and changes in localization of dynamin with or without GnRH 
stimulation. Dynamin localizes in the lamellipodia and membrane protrusions with 
actin and actin binding protein (ABP) after GnRH stimulation. Inhibiting the GTPase 
activity of dynamin via dynasore decreased ERK activation, but did not alter JNK 
phosphorylation. Dynasore treatment also led to inhibition of actin reorganization after 
treatment with GnRH, and subsequent decreases in L-type Ca
2+
 channel activity, as 
measured by TIRF microscopy described above. Either inhibiting dynamin or the L-
type Ca
2+
 channels decrease calcium influx at the membrane. Actin cytoskeletal 
remodeling, necessary for gonadotropin secretion, is dependent on cortactin 
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localization and these studies implicate dynamin signaling and calcium influx through 
L-type Ca
2+
 channels in this process.
125
  
 
A role for PI3K/PI4K signaling within the GnRH signaling network 
The role of phosphatidylinositol-3-, and phosphatidylinositol 4-kinases (PI3K 
and PI4K, respectively) in ERK activation was recently investigated by several 
groups.
130,131
 Clonal αT3-1 and LβT2 cells treated with phorbol ester, a PKC agonist, 
showed persistent ERK1/2 phosphorylation (pERK) consistent with a known role for 
PKC signaling in ERK activation in gonadotropes. Interestingly, pharmacological 
inhibition of PI3K or PI4K resulted in reduced ERK phosphorylation following GnRH 
and EGF treatments.
130
 The gonadotropin subunits were variably affected by inhibition 
of PI3K/PI4K. Common glycoprotein αGSU production was inhibited by PI3k/PI4K 
inhibition, LHβ production was unaffected, and FSHβ production was increased, 
underscoring the gonadotrope’s ability to differentially regulate FSH and LH 
production, likely via separate pathways.
130
 While complex, these studies supported 
the conclusion that PI3K/PI4K is involved in the regulation of ERK activity and 
gonadotropin production via the GnRHR in important gonadotrope cell lines and it 
will be critical to examine the role and requirement of these pathways in vivo using 
genetically modified mice to fully realize the impact of these pathways on fertility. 
 
A role for DICER in the gonadotrope 
Another important factor in gonadotrope cell function is the intracellular 
enzyme DICER. DICER is a member of the RNAse III family and functions to cleave 
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double stranded RNA molecules involved in the production of small interfering- and 
micro-RNAs in cells. Wang and colleagues created a novel gonadotrope-specific CRE 
mouse, using a Fshb promoter-Cre recombinase fusion to specifically target 
gonadotropes. Mating this CRE line with a conditional DICER
f/f
 allele resulted in the 
specific deletion of DICER in murine gonadotropes.
78
 Loss of DICER in gonadotropes 
reduced gonadotropin production, testes size, and resulted in complete infertility. In 
female mice, this deletion resulted in hypoplastic uteri and smaller ovaries; the ovaries 
lacked corpora lutea suggestive of ovulation failure; and these mice exhibited 
abnormal estrous cycles and low circulating levels of progesterone. The FSHβ-cre 
mouse line provides an important opportunity for specific Cre expression and 
conditional gene deletion in the pituitary gonadotropes since other gonadotrope-
specific Cre lines have the potential for mis-expression in tissues within the 
reproductive axis other than gonadotropes. Further, this new mouse model implicates 
an important role for DICER and RNA metabolism within the gonadotrope where loss 
of DICER results in a marked infertility.
78
 The implications for how DICER and RNA 
metabolism affect reproductive function is likely to be far-reaching due to the 
complexity of how individual microRNAs impact differentiated gonadotrope cell 
function.  
 
Relative effects of GnRH and a common agonist, Buserelin 
Both human and veterinary medicine utilize buserelin, a GnRH agonist, for 
treatment of infertility.
132–135
 However, there are known off-target effects, such as 
neuropathic enteritis associated with the use of this agonist in vivo.
135,136
 Nederpelt 
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and colleagues used whole cell impedence, as well as inositol phosphate accumulation 
assays to understand the differences between the effects of the native GnRH and the 
pharmacologically super active agonist buserelin. As anticipated, these studies 
revealed buserelin had a higher efficacy and potency, when compared to GnRH.
137
 
Along with higher efficacy, buserelin also had a longer binding duration than GnRH. 
When cells were treated with either ligand and washed, approximately 80% of 
buserelin treated cells remained active after washing, while only 30% of GnRH treated 
cells remained active.
137
 Understanding the differences between the pharmacokinetics 
of the endogenous ligand and the agonist can aid in creating treatment protocols and 
informing clinical decisions. Recent work has shown buserelin has a role in treatments 
besides fertility, and understanding its mechanism of action can help improve 
treatments for conditions such as cancer, embryonic mortality and cryptorchidism.
138–
145
  
 
Novel modulators of GnRH action 
Phoenixin 
  GnRH is the primary regulator of LH biosynthesis and secretion while GnRH 
and activin are important regulators of FSH.
81,146
 More recently other modulators of 
GnRH action have come to light. A potential role for Phoenixin was recently 
described by Yosten and colleagues.
147
 Using a genome-wide screen, this group 
identified novel protein sequences that were conserved across species. Phoenixin was 
identified in this screen, found in highest abundance within the magnocellular and 
parvocellular paraventricular nucleus, as well as the supraoptic nucleus in the 
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hypothalamus. When combined with GnRH administration, Phoenixin increased LH 
production and release, ostensibly through increasing expression of the GnRHR.
147
 In 
vivo, rats treated with siRNA to knock down Phoenixin expression displayed disrupted 
estrous cycle behavior and reduced GnRHR within the pituitary gland suggesting this 
peptide may play an important role within the neuroendocrine axis.
147
 
Treating hypothalamic derived GT1-7 cells with Phoenixin increased both the 
GnRH and GnRHR expression, indicating its potential importance within the HPG 
axis. Although speculative, Phoenixin appears to act on GPR173 in the hypothalamus, 
which also couples with a metabolite of GnRH (GnRH-(1-5)) to increase GnRHR 
expression.
148,149
 GPR173 is a G-protein coupled receptor linked to Gαs and cAMP 
signaling. Consistent with this observation, the Belsham group linked 
Phoenixin/GPR173 signaling to PKA/CREB and C/EBPβ activation and up-regulation 
of a number of gene targets including GnRH, GnRHR, Kisspeptin and Oct-1 
expression in hypothalamic neuronal cell lines.
150
 Coupled with evidence from 
knockdown studies described above, Phoenixin is emerging as an important regulator 
of reproductive function and a potential modulator of GnRH action.  
 
Intracellular reactive oxygen species (ROS) 
Kim and Lawson demonstrated in both the gonadotrope –derived LβT2 cell 
line and in primary pituitary cell cultures that GnRH stimulation increased 
intracellular reactive oxygen species (ROS) such as superoxide radicals, hydroxyl 
radicals and hydrogen peroxide.
151
 These free radicals are produced from NADPH 
oxidase (NOX) and dual oxidase (DUOX) enzyme family, which use NADPH as an 
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electron donor, and create ROS as a by-product.
152
 ROS signaling and NOX family 
members have been linked to control of the reproductive axis; however, their specific 
role(s) in the pituitary gonadotrope had not yet been elucidated.
152–155
 NOX/DUOX 
subunit mRNAs and protein levels were increased by GnRH stimulation in mouse 
pituitary cells in primary culture and gonadotrope cell lines.
151
 Pharmacological 
inhibition of NADPH oxidase decreased GnRH-induced ROS production indicating 
that the NOX/DUOX pathway is activated through GnRH signaling. Interestingly, 
NOX/DUOX enzymes appear to be necessary for JNK and ERK activation and 
subsequent regulation of the gonadotropin subunit genes; inhibition of NOX/DUOX or 
the use of a ROS scavenger decreased GnRH-induced JNK and ERK activation. 
DUOX1 and DUOX2 are both regulated by intracellular Ca
2+
 stores and inhibition of 
DUOX enzyme activity reduced calcium-induced ERK activation; interestingly, 
inhibition of NOX activity did not affect MAPK activation state induced by GnRH 
suggesting that DUOX activity may hold primary importance. DUOX inhibition also 
decreased GnRH-induced immediate early gene responses, which led to decreased 
gonadotropin subunit production and secretion.
151
 FSHβ appears to be preferentially 
mediated by Duox2. This important link between cellular metabolism and gonadotrope 
cell function may have important implications on how the reproductive system 
perceives and manages adverse metabolic conditions.
151
  
 
The GnRHR and extracellular ATP production 
The GnRHR is present within discrete plasma membrane domains termed 
membrane rafts within gonadotropes. Productive signaling between the GnRHR and 
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the ERK pathway requires localization of the GnRHR in rafts.
41,43,156
 Recently, our 
own lab carried out proteomic studies examining the co-localization of the GnRHR 
with other potential signaling proteins within the raft domain using 
immunoprecipitation of the GnRHR and flotillin 1 (a raft marker) followed by mass 
spectrometry.
157
 These studies revealed that the GnRHR and flotillin 1 colocalized 
with the F0F1 ATP synthase complex in the membrane rafts. The ATP synthase 
complex is normally found in the inner mitochondrial leaflet and is central to ATP 
production with a cell; the presence of the ATP synthase complex and subunits of the 
electron transport chain at the cell surface were unexpected. Using αT3-1 cells, 
subunits of the ATP synthase complex and electron transport chain were confirmed by 
immunoprecipitation, flow cytometry and cell surface biotinylation studies leading to 
the determination that the catalytic surface of the complex pointed outward into the 
extracellular space.
157
 This spatial configuration was confirmed by analyzing the 
production of extracellular ATP in the media when αT3-1 cells and whole mouse 
pituitary explants were treated with ADP as a substrate for synthase activity. 
Extracellular ATP synthesis could be inhibited by a number of inhibitors to the 
synthase, perhaps the most revealing was removal of inorganic phosphate from the cell 
culture media or with prolonged GnRH exposure which appeared to downregulated 
the ATP synthase from the cell surface of the gonadotrope. Using a sheep model, 
substrate for the ATP synthase (ATP/ADP) was detected in plasma from the 
hypothalamic-pituitary portal vasculature indicating that hypothalamic input into the 
system was possible. Extracellular ATP synthesis appears to plays a modulatory role 
in gonadotropin secretion. GnRH-induced LH secretion was increased in the presence 
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of extracellular ADP/ATP suggesting that extracellular ATP “tone” could modulate 
the LH secretion.
157
 While the in vivo implications of this finding are not entirely 
clear, extracellular ATP levels may be an important modulator of GnRH-induced LH 
secretion. 
 
Gonadotropin inhibiting hormone 
Gonadotropin inhibitory hormone (GnIH) is a hypothalamic decapeptide that 
inhibits the synthesis and release of gonadotropins, acting on both the hypothalamic 
GnRH neurons as well as pituitary gonadotropes.
158,159
 Originally, this peptide was 
found to be regulated by melatonin, and implicated in seasonal reproductive 
differences, especially in avian species.
158,160
 As research progressed, a link between 
environmental stimuli such as weather, stress, and GnIH was uncovered. This link was 
expanded to include poor reproductive performance during times of stress, where 
GnIH levels is an important modulator of the reproductive axis.
161
 This correlation 
was confirmed in an ovine model examining secretion of GnIH into the hypothalamic 
portal system. Release of GnIH from the median eminence (ME) occurs at higher 
levels during the nonbreeding season, ostensibly inhibiting reproduction.
162
 Testing 
the direct relationship between environmental stress and GnIH secretion, Clarke and 
colleagues subjected ewes to both long and short term stressors. Long term 
administration of adrenocorticotropin decreased LH secretion, increased the number of 
GnIH-containing neurons and GnIH mRNA levels in individual GnIH-neurons but did 
not affect the levels of GnIH detected in plasma at the ME. Moreover, these stressors 
appeared to increase the number of GnIH nerve fibers that occurred in proximity to 
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GnRH neurons. Interestingly, short-term stressors such negative auditory stimuli (dog 
barking) followed by induction of hypoglycemia with insulin or a separate stressor 
induced by LPS administration did not change GnIH levels at the ME, but increased 
neuronal activation of GnIH neurons and the contact fibers between GnIH and GnRH 
cells.
163
 These new studies provide compelling evidence that GnIH is a potent negative 
regulator of reproduction during times of chronic and acute stressors. Manipulation of 
the GnIH systems has clear and important implications as a pharmacological target for 
GnRH inhibition.  
 
CONCLUSIONS 
Understanding and controlling reproduction is critical in the face of a growing 
global population and sustainability of food supplies to support such a population. 
Conversely, issues related to infertility also strain health care, particularly in 
developed countries. These issues span human medicine and species barriers; for 
example, controlling pet populations and those of invasive species, while improving 
reproduction of critically endangered species has important relevance. Moreover, 
insuring adequate production of food and fiber often relies upon efficient reproductive 
strategies. GnRH, a potent regulator of reproduction as an integral and required part of 
the HPG axis; GnRH and the GnRHR are critical targets for manipulating 
reproduction. Thus, understanding the potential modulators and inhibitors of GnRH 
action in the pituitary and hypothalamus, as well as the function and intricacies of the 
intracellular signaling pathways increases the ability to modulate gonadotrope cell 
behavior. Similarly, understanding non-canonical signaling pathways from outside of 
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the HPG axis has helped to identify and characterize novel targets for 
pharmacological/medical intervention in the control of fertility.  
This introduction has worked to highlight recent advances in research 
involving GnRH and GnRHR action. This work has uncovered novel binding partners, 
activation mechanisms, functional behavior and signaling mechanisms regarding 
GnRH. However, more areas of research exist, especially in understanding the clinical 
implications and treatment of IHH. Specifically, understanding the progression of IHH 
and the result of long term loss of gonadotropin stimulation has been under 
investigated to this point. Additionally, the role of GnRH and GnRHR in the placenta 
has not been thoroughly explored, especially in the context of ERK signaling. IHH 
patients have difficulty with conception and throughout pregnancy, for reasons that 
have not been thoroughly elucidated (Chapter 3). In addition to understanding 
different facets and clinical implications of the loss of GnRH signaling, gonadotropins, 
and ERKs in various physiologic time points and tissues, we hoped to elucidate 
additional targets and modulators of GnRH signaling in the context of the ERK1/2 
deficient mouse model system (Chapter 2). My dissertation research seeks to define 
physiological mechanisms both in the context of the HPG axis and other aspects of 
reproduction, as well as modulators of GnRH action related to other areas such as 
metabolism and metabolic regulation of reproductive potential (Chapter 4). We 
hypothesize ERK1/2 signaling in GnRHR expressing cells is a central regulator of 
reproduction in multiple areas, including aging, pregnancy and metabolism. 
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CHAPTER 2 
 
 
 
 
 
 
 
 
 
Sex- and age-specific impacts of ERK loss within the pituitary gonadotrope 
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ABSTRACT 
ERK (extracellular signal-regulated kinase) signaling regulates the 
reproductive axis, but specific mechanisms have yet to be completely elucidated. 
Conditional gene targeting allows isolation and analysis of ERK-dependent 
mechanisms controlling gonadotrope cell function. In the present study, an ERK1 null 
and ERK2 floxed mouse was combined with gonadotrope-specific Cre (GRIC) driver. 
The mice were characterized for reproductive abnormalities to understand the role of 
ERK signaling in the gonadotrope during aging. As observed previously using a 
different pituitary-specific Cre driver, female ERK double knockout (ERKdko) 
animals were hypogonadotropic, leading to infertility through altered estrous cyclicity 
and anovulation. Transcript levels of four gonadotrope specific genes (GnRHR, and 
the three gonadotropin subunits) were reduced in pituitaries at estrus. Further, post-
castration response to endogenous GnRH stimulation was blunted. As females aged, 
they exhibited abnormal ovarian histology, as well as increased bodyweight. ERKdko 
males were initially less affected, showing moderate subfertility up to 6 months of age. 
Male ERKdkos also displayed a blunted response to endogenous GnRH following 
castration. By 12 months of age, ERKdko males had reduced testicular weight and 
sperm production. By 18 months of age, the ERKdko males retained only 23% of 
sperm production occurring coincident with reduced testis and seminal vesicle weight, 
and marked seminiferous tubule degeneration. These studies support speculation that 
hypogonadotropism secondary to loss of ERK signaling within the reproductive axis 
has important impacts on reproductive competence in both sexes and shed new light 
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on the pathophysiology of aging in idiopathic hypogonadotropic hypogonadism 
(IHH).  
 
INTRODUCTION 
The hypothalamic-pituitary-gonadal (HPG) axis regulates reproduction 
through multiple interconnected endocrine feedback loops.
1
 The hypothalamus 
secretes gonadotropin releasing hormone (GnRH) from the median eminence, which 
travels through the hypophyseal portal system to act upon gonadotrope cells in the 
anterior pituitary.
2,3
 These gonadotrope cells are characterized by expression of GnRH 
receptor (GnRHR), and comprise approximately 10- 15% of the pituitary cells.
4
 In 
response to GnRH stimulation, the gonadotrope produces two peptide hormones: 
luteinizing hormone (LH) and follicle stimulating hormone (FSH).
5
 They are made 
from two gonadotropin specific subunits, LHβ and FSHβ, which combine with a 
common glycoprotein subunit (αGSU), to create bioactive gonadotropins.6 In turn, 
these hormones act upon the gonads to control steroidogenesis and gametogenesis.
7,8
 
Isolating the role of specific signaling pathways and genes in discrete tissues or 
cell types in the HPG axis aids in understanding both the function of the axis and can 
lead to increased ability to manipulate, augment or restrict reproductive endocrine 
function. To this end, we focused on the role of extracellular signal-regulated kinase 1 
and 2 (ERK1/2) in the pituitary gonadotropes. Whole body knockout of ERK2 results 
in embryonic lethality, but ERK1 null animals are viable and fertile.
9–11
 Therefore, 
understanding the role of ERK2 in reproduction requires a tissue specific knockout. In 
the pituitary, ERK is necessary for immediate early gene activation. Activation of 
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factors like early growth response protein 1 (Egr1), c-Fos, activating transcription 
factor 3 (ATF3), and Nur77, along with the gonadotropin hormone subunits, is crucial 
for appropriate response to GnRH stimulation and are all ERK signaling-
dependent.
12,13
 Thus, ERK1/2 signaling is an integral regulator of gonadotrope cell 
function, as well as the function of multiple parts of the HPG axis.
14–18
  
Multiple labs, including our own, have used gonadotrope specific models to 
understand the role of genes or signaling intermediates in the neuroendocrine axis.
19–21
 
Previously, Bliss et al used the αGSU promoter regulating Cre recombinase expression 
to understand the role of ERK1/2 in pituitary gonadotropes.
20
 While very useful, 
expression of GSU is not specific to pituitary gonadotropes, as the Cre was also 
expressed in thyrotropes. Alteration of the thyroid hormone axis has clear effects on 
reproductive potential leaving open questions of how exactly to interpret the role of 
ERK signaling within the reproductive axis. A novel gonadotrope specific Cre, the 
GnRHR IRES Cre (GRIC) mouse, has more recently been used to study ablation of 
specific genes in the pituitary gonadotropes.
4,22
 This Cre driver was knocked in 
downstream of the GnRHR coding region, along with an IRES sequence. This results 
in a bicistronic mRNA, and independent translation of the GnRHR and the Cre 
recombinase.
4
 GnRHR is activated at e13.5, markedly later than e9.5, when the αGSU 
Cre was activated, potentially accounting for some of the differences between the two 
models. 
20,22
 
Utilization of the GRIC model, in combination with an ERK1
-/-
, ERK2
fl/fl
 
background, provides specific ablation of ERK2 localized to the gonadotrope within 
the pituitary. However, this Cre has been shown to be expressed in the testes and 
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placenta as well
19
 (Unpublished data, Roberson lab). The current studies more fully 
characterize the reproductive phenotype of the ERK deficient males regarding the 
impact of ERK signaling loss on gonadotrope cell function and fertility. ERK 
signaling is altered in cellular aging, senescence, and oxidative damage, and alteration 
in ERK expression can change cellular response to these insults.
23–29
 Based upon these 
observations we investigated sex and age-related impacts of ERK1/2 loss within the 
reproductive system. 
Both males and females show changes in the HPG axis as they age. Changes in 
gonadotropins, steroid hormones and gonadal function have been documented in aging 
animals and humans. In rodent models, serum gonadotropins have been shown to have 
altered secretion and cyclicity in aging female animals, with decreased LH and 
increased FSH, 
30,31
 as well as altered steroidogenesis and decreased serum 
progesterone.
25
 Interestingly, these effects could be mitigated by repeated pregnancy 
or progesterone supplementation.
33
 Males also display the same alterations in 
gonadotropin levels, decreased quality and quantity of LH and increased FSH, 
corresponding inversely to sperm count.
33–35
 Although ERK’s role in reproduction has 
been well characterized, understanding the effects of ERK loss in the pituitary, and 
subsequent hypogonadism, as animals age could help to understand and mitigate the 
effects of IHH. 
We investigated the effects of ERK1/2 loss in aged animals, as well as those of 
reproductive age.
23–27
 The present studies show that loss of ERK signaling clearly 
impacts the timing of reproductive senescence in males and female that is likely 
attributable to loss of gonadotropic stimulation and or local effects of GRIC-medicated 
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ERK deletion in the testis. Collectively our studies provide valuable insights into the 
effect(s) of hypogonadatrophic hypogonadism on gonadal competence as mice and 
potentially human patients age.  
 
MATERIALS/METHODS 
ANIMALS 
ERK1 null (ERK1
-/-
), ERK2 floxed (ERK2
fl/fl
) and GnRH receptor IRES Cre 
(GRIC) mice have been described previously.
4,19,20
 ERK1/2 knockout animals were 
designated ERKdko (ERK1
-/-
, ERK2
fl/fl
, Cre
+/-
) and compared with Control animals 
(ERK1
-/-
, ERK2
fl/fl
, Cre
-/-
). Animals were handled in compliance with the Cornell 
University Institutional Animal Care and Use Committee. For breeding challenge, 
males of both genotypes were paired with one control and one ERKdko female. 
Females were checked daily for copulatory plugs, and monitored for changes in body 
weight and signs of pregnancy and parturition.  
 
GENOTYPING 
Genomic DNA was isolated from tail snips (3 mm), or an equivalent quantity 
of other tissues as indicated, using a E-Z Tissue DNA Kit (Omega Biotek, Norcross, 
GA) per manufacturer’s instructions. Routine PCR genotyping was performed on 
animals as previously described.
36
 PCR confirmation of ERK1 knockout, ERK2 flox, 
Rosa26 reporter, Stra8 cre, and GnRHR Cre alleles were performed with primers 
listed below.  
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Primer 
 
Sequence (5’ to 3’) 
Rosa26 
Reporter 
Rosa26 Forward TAA GCC TGC CCA GAA GAC TC 
Rosa26 Reverse AAA GTC GCT CTG AGT TGT TAT 
Rosa26 Common 
TCC AGT TCA ACA TCA GCC GCT 
ACA 
ERK1 
ERK1 Forward AAG GTT AAC ATC CGG TCC AGC A 
ERK1 Reverse AAG CAA GGC TAA GCC GTA CC 
ERK2 
ERK2 Forward AGC CAA CAA TCC CAA CCC TG 
ERK2 Reverse GGC TGC AAC CAT CTC ACA AT 
GnRHR 
GnRHR Forward GAA CTA CAG CTG AAT CAG TC 
GnRHR Reverse CTC TAA CAA ACT CTG TAC A 
GnRHR 
Homozygous 
CGG AAT TCA TCG ATC ATA TCA 
GAT CC 
Stra8 
Stra8 Forward GTG CAA GCT GAA CAA CAG GA 
Stra8 Reverse AGG GAC ACA GCA TTG GAG TC 
 
HISTOLOGY 
Tissues were fixed in 10% formalin, paraffin embedded, serially sectioned at 
4µm, and stained with hematoxylin and eosin using standard histological techniques. 
Sections were scanned and digitized using an Aperio Scanscope (Vista CA), and 
analyzed using ImageScope (Leica Biosystems, Buffalo Grove, IL). For 
characterization of the ovarian follicular population, every third section was examined 
microscopically for identification of luteal tissue in both ERKdko and control females. 
For characterization of the testicular tissues, every third section was examined 
microscopically for gross evaluation. The largest sections were chosen, choosing 4 
slides total, and 20 seminiferous tubules were chosen for analysis from each section on 
all slides in both ERKdko and control males. Tubule diameter was averaged between 
all slides and animals from each group.  
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VAGINAL CYTOLOGY 
The vaginal vault was swabbed to make a cytological smear. The smear was 
stained with Wright’s Giemsa stain, and examined with light microscopy. 100 cells 
were counted, and epithelial cells and leukocytes were differentiated on the basis of 
morphology. An animal was deemed to be in estrus with >85% superficial epithelial 
cells.  
 
EPIDIDYMAL SPERM COUNT 
After euthanasia, testes and epididymis were dissected free. The epididymis 
was placed in 1ml 4 percent BSA in PBS, and tubules extracted. The preparation was 
incubated (32
o
F) for 20 minutes. 480ul of 10% formalin was mixed with 20ul of the 
preparation, and placed on a hemocytometer, and sperm were counted to determine 
sperm numbers and assessed for morphology. 
 
GONADECTOMY 
Ovariectomy and castrations were performed under Avertin (Tribromoethanol, 
Sigma-Aldrich, St. Louis, MO) general anesthesia, with standard aseptic techniques. 
The castrations were performed with ventral midline incisions and the ovariectomies 
were performed with flank incisions. They were given ketoprofen postoperatively for 
pain control. The animals were euthanized 7 days post-operatively, and blood and 
pituitaries were collected.  
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SERUM PEPTIDE HORMONE ANALYSIS 
The blood was allowed to clot for 15 minutes, then centrifuged for 10 minutes 
at 2500 rpms. The serum was collected and frozen at -80 F. Pituitaries were snap 
frozen. Serum was analyzed at University of Virginia Ligand Core through RIA 
multiplex, in duplicate or using in-house FSH and LH assays as previously 
described.
37
 Testosterone was assayed using a commercially available kit (IBL, 
Minneapolis, MN) per the manufacturer’s instructions. 
 
RNA ISOLATION AND QUANTITATIVE PCR 
Tissues were collected and Trizol (ThermoFischer, Waltham, MA) extraction 
was performed per manufacturer’s instructions to isolate total RNA. Reverse 
transcription in 1000ug reactions was performed using the High-Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, Foster City, CA) according to 
manufacturer directions. qRTPCR was performed using SYBRGREEN 
(ThermoFisher, Waltham, MA) and primers listed below. Amplifications were carried 
out using a BioRad CFX96 Touch Real-Time OCR Detection System (BioRad, 
Berkeley, CA). RNA levels were standardized using the internal control Gapdh and 
assessed using ddCT methodology.
20
 
Primer Sequence (5’ to 3’) 
Glyceraldehydes-3-
phosphate 
dehydrogenase 
Gapdh forward ATGTTTGTGATGGGTGTGAA 
Gapdh reverse ATGCCAAAGTTGTCATGGAT 
Gonadotropin 
Releasing Hormone 
Receptor 
GnRHR forward TGCTCGGCCATCAACAACA 
GnRHR reverse GGCAGTAGAGAGTAGGAAAAGGA 
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Luteinizing Hormone 
β-subunit 
LHβ forward CTGAGCCCAAGTGTGGTGTG 
LHβ reverse GACCATGCTAGGACAGTAGCC 
Follicle Stimulating 
Hormone β-subunit 
FSHβ forward GCCATAGCTGTGAATTGACCA 
FSHβ reverse AGATCCCTAGTGTAGCAGTAGC 
α-Glycoprotein Subunit 
α-GSU forward TCCAGGGCATATCCCACTCC 
α-GSU reverse CATTTCCCATTACTGTGGCCTTA 
 
Β-Galactosidase in vitro assay 
For β-galactosidase in vitro assays, tissues were fixed in 4% 
paraformaldehyde/PBS for 1 hour at 4°C, then rinsed 3 times for 30 minutes each in a 
rinse buffer (100 mM sodium phosphate (pH 7.3), 2 mM MgCl2, 0.01% sodium 
deoxycholate, 0.02% NP-40 (by volume)). Sections were stained overnight in staining 
buffer (rinse buffer with 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 
1 mg/ml X-gal). Sections were fixed overnight in 10% formalin, then washed with 
distilled water twice for 30 minutes. They were dehydrated by sequential ethanol 
washes (70%, 95%, twice in 100%, then washed in methyl salicylate until the tissue 
cleared. 
 
STATISTICS 
Pairwise comparisons were made by Student's t-test for most data. When 
appropriate, a one-way analysis of variance was used, with Tukey’s post-hoc test. All 
data are expressed as means ± standard error of the mean. A p value of <0.05 was 
considered statistically significant. 
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RESULTS: 
ERKdko females are infertile, hypogonadotropic, and anovulatory 
Female control and ERKdko mice were paired with control males and 
monitored daily for copulatory plugs. While 100 percent of control females exhibited 
copulatory plugs within the first 3 days of pairing, only 33 percent of ERKdko females 
exhibited copulatory plugs when paired with males for 30 days. All control females 
had litters at approximately 20 days post plug, while no ERKdko animals were 
observed to have litters (Table 1).  
Due to the complete infertility of ERKdko animals, vaginal cytology was used 
to assess dynamics of the estrous cycle. Control animals had a cycle length of 5.3 ± 
0.26 days. ERKdko animals had significantly longer interestrus interval, with 9.2 
±1.01 days between estrus (Table 1). The ERKdko animals showed normal diestrus 
and estrus cytology (Figure 1A and Table 1); however, both diestrus and estrus 
intervals were significantly prolonged, with a clear lack of normal periodicity seen in 
control females
20
. To better understand the relationship between estrous cycle 
behavior and ovarian activity, ovaries were collected at estrus and examined by 
histology. While both control and ERKdko animals showed ovarian follicles in 
various stages of maturation, control ovaries displayed an average of 6.3 corpora lutea 
per ovary compared to a conspicuous absence of CLs in the ERKdko ovaries, 
indicating an anovulatory phenotype (Figure 1B and Table 2). Body weight, uterine 
wet weight and ovarian weights at estrus were not significantly different between 
control and ERKdko animals at 6 months of age (Table 2).  
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To assess additional impacts of ERK deletion on gonadotrope cell function in 
female mice, we utilized qPCR to determine the abundance of the four genes known to 
define the gonadotrope cell lineage (LHβ, FSHβ, αGSU, and GnRHR). These studies 
demonstrate decreased mRNA expression of all four gonadotrope genes at estrus in 
ERKdko females, compared to control females (Figure 1C). This was consistent with 
basal levels of FSH and LH in circulation in ERKdko and control females (Figure 2A 
& B; sham).  
To determine the response of ERKdko and control females to endogenous 
hyper-stimulation by GnRH, animals were sham operated or ovariectomized and then 
euthanized after 5 days to analyze changes in serum gonadotropins. There was a 
significant increase in serum FSH and LH following ovariectomy in control animals 
which did not occur to the same extent in ovariectomized ERKdko females (Figure 
2A, B). These findings were generally consistent with previously published data from 
our group using the GSU Cre driver with the following exception.20 Current use of 
the GRIC Cre driver resulted in a more robust inhibition of response of FSH following 
castration which may reflect greater penetrance of the GRIC Cre in this model.  
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TABLE 1: ERKdko animals have significantly longer estrous cycles, spend more time 
in both diestrus and estrus, have smaller litters and are anovulatory compared to 
control animals  
 Control  GRIC ERKdko  
Estrous cycle 
length (d) 
5.3 + 0.3 
a
 
(n=5) 
9.2 + 1.0 
b
 
(n=5) 
Mean Litter size  7.0 + 0.6 
a
 
(n=3) 
0 
b
 
(n=6) 
Time in estrus (d)  1.4 + 0.1 
a
 
(n=5) 
3.2 + 0.5 
b
 
(n=5) 
Time in diestrus (d)  1.9 + 0.2 
a
 
(n=5) 
4.3 + 0.5 
b
 
(n=5) 
CL/ovary  6.3 + 1.3 
a
 
(n=6) 
0 
b
 
(n=6) 
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Figure 1: ERKdko are infertile due to hypogonadotropism and anovulation A) 
ERKdko animals exhibit irregular and prolonged estrous cycles compared to control 
animals. B) Ovaries from ERKdko animals showed no CLs, compared to 
approximately 6 per ovary for control animals. C) ERKdko animals had significant 
reduction in all four signature gonadotrope gene transcript levels (αGSU, LHβ, FSHβ, 
GnRHR) compared to control animals. (p<0.05) D) These transcript levels remained 
significantly lower in aged ERKdko animals (12 months), when compared to aged 
control littermates (p<0.05).  
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Table 2: Aged (12 month) ERKdko animals showed increased body weight, but 
decreased uterine and ovarian wet weight as a percentage of body weight  
 Control  GRIC ERKdko  
Body weight (gm; 6 
mos)  
24.3 + 1.4
a
 
(n=14) 
27.4 + 1.3
a
 
(n=21) 
Body weight (gm; 12 
mos)  
28.9 + 0.6
a
 
(n=23) 
36.3 + 1.2
b
 
(n=12) 
Ovarian WT/BW (mg; 
6 mos)  
3.0x10
-3
 + 0.1x10
-3a
 
(n=4) 
2.2x10
-3
 + 0.1x10
-3a
 
(n=4) 
Ovarian WT/BW (mg; 
12 mos)  
1.2x10
-3
 + 0.09x10
-3a
 
(n=13) 
0.8x10
-3
 + 0.1x10
-3b
 
(n=7) 
Uterine WT/BW (gm; 
6 mos)  
0.05 + 0.1
a
 
(n=4) 
0.03 + 0.003
a
 
(n=4) 
Uterine WT/BW (gm; 
12 mos)  
0.04 + 0.004
a
 
(n=13) 
0.02 + 0.001
b
 
(n=7) 
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Figure 2: ERKdko animals have a blunted gonadotropin response to castration. A) 
Control animals showed significant increases in LH following castration and 
maximized endogenous GnRH. This effect was blunted in ERKdko animals, who did 
not show a significant difference in LH levels between castrated and sham op females. 
B) Similarly, ERKdko animals showed a blunted FSH response to endogenous GnRH 
following castration. (p<0.05).  
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Female ERKdko animals show altered age-related changes in body weight and 
ovarian histology 
Female control and ERKdko animals were maintained until approximately 12 
months of age. These animals received identical access to food and water and were not 
given the opportunity to reproduce. At the time of weaning through 6 months of age, 
there were no differences in body weight between genotypes. At 12 months of age, 
body weight was ~25% higher in ERKdko females compared to control females 
(Table 2). Absolute ovarian and uterine weights were reduced in ERKdko older 
females and this was amplified when presented as ovarian and uterine weight/unit 
body weight compared to the control genotype (Table 2).  
Aged ERKdko females (12 months) also showed signs of abnormal ovarian 
histology presumable reflecting premature reproductive aging and senescence. 
Consistent with the younger ERKdko females, aged ERKdko animals showed an 
absence of CLs. Further, aged females showed loss of normal ovarian architecture 
with abnormal accumulations of extra-cellular matrix and regions of marked 
acellularity. Ovarian histology in control animals appeared unremarkable with 
multiple CLs present and normal architecture (Figure 3A & B). Comparison of uterine 
histology between genotypes in the aged females was unremarkable (data not shown) 
suggesting that changes in ovarian architecture were specific within the reproductive 
axis.  
To understand the changes in pituitary gonadotrope function, we performed 
qRT-PCR on pituitaries from 12 months old females. Transcript levels of the four 
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gonadotrope genes were not significantly different between 6 month old and 12 month 
old control animals. However, all of these transcript levels were significantly reduced 
in aged ERKdko animals. LHβ showed the most significant reduction, with an 11-fold 
decrease compared to control animals (Figure 1D). 
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Figure 3: Aged ERKdko animals show alterations in ovarian histology. A) 
ERKdko animals show abnormal accumulations of extra-cellular matrix and regions of 
marked acellularity. B) Higher magnification of areas of acellularity and ECM 
accumulation  
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Male ERKdko animals show moderate subfertility 
  Males of both genotypes were capable of producing copulatory plugs, and 
there was no difference between control and ERKdko males in days to first plug or 
number of copulatory plugs needed to produce a pregnancy (data not shown). 
However, ERKdko males sired smaller litters compared to control males (Figure 4A). 
There was no significant difference in testis weight between control and ERKdko 
males at 6 months of age, even when normalized to body weight (Table 3). However, 
ERKdko males displayed a mild, but statistically significant reduction in sperm count 
at 6 months of age (Table 3). This corresponded with a modest reduction in 
seminiferous tubule area (Figure 4B). Sperm morphology was grossly normal for both 
genotypes (data not shown).  
To assess the effect(s) of ERK deletion on gonadotropin subunit and GnRHR 
mRNA levels, qPCR was performed on pituitaries from control and ERKdko males at 
6 month of age (Figure 4C). Consistent with responses in ERKdko females at estrus 
(Figure 1C), ERKdko males displayed reduced expression of LH and FSH  mRNAs 
compared with control males. Common glycoprotein hormone  subunit and GnRHR 
mRNAs were not statistically different between genotypes.  
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Figure 4: ERKdko males show reduced fertility. A) ERKdko animals had a 
significantly reduced litter size compared to control animals (4.8 versus 7.1 pups per 
litter) B) ERKdko animals have significantly reduced seminiferous tubule area 
compared to control animals. C) 4 month old ERKdko animals have significantly 
reduced transcript levels of LHβ and FSHβ, compared to control animals. Reductions 
in αGSU and GnRHR were not significant. D) 18 month old ERKdko animals had 
significant reduction in αGSU, LHβ, and FSHβ transcript levels compared to controls. 
(p<0.05 for all significant differences)  
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Table 3: Male ERKdko animals show reduced testis to body weight ratio, seminal 
vesicle weight and sperm count as they aged, when compared to age matched controls  
 Control  GRIC ERKdko  STRA8 ERKdko  
Testis 
(mg)/BW (g) 
6 mos  
3.6x10
-3
+0.1x10
-3a
 
(n=7) 
3.4x10
-3
+0.4x10
-3a
 
(n=6) 
 
Testis 
(mg)/BW 
(gm) 
12 mos  
3.8x10
-3
+ 0.1x10
-3a
 
(n=14) 
2.5x10
-3
+0.1x10
-3b
 
(n=12) 
 
Testis 
(mg)/BW 
(gm) 
18 mos  
4.1x10
-3
+0.1x10
-3a
 
(n=14) 
2.8x10
-3
+0.2x10
-3b
 
(n=12) 
3.7x10
-3
+ 0.1x10
-3c
 
(n= 6) 
Seminal 
Vesicle (mg) 
6 mos  
288.2 + 22.3
a
 
(n=7) 
250.2 + 16.6
a
 
(n=6) 
 
Seminal 
Vesicle (mg) 
12 mos  
395.3+ 54.3
a
 
(n=14) 
258.4 + 29.6
a
 
(n=12) 
 
Seminal 
Vesicle (mg) 
18 mos  
362.7 + 24.8
a
 
(n=14) 
257.8+ 8.2
b
 
(n=12) 
429.3+ 60.5
c
 
(n= 6) 
Total 
epididymal 
sperm  
6 mos  
20.6x10
6
 + 
0.8x10
6a
 
(n=7) 
17.0x10
6
 + 
1.1x10
6b
 
(n=6) 
 
Total 
epididymal 
sperm  
 12 mos  
14.7x10
6
 + 
0.4x10
6a
 
(n=14) 
7.8x10
6
 + 0.2x10
6b
 
(n=12) 
 
Total 
epididymal 
sperm  
18 mos  
13.4x10
6
 + 
0.6x10
6a
 
(n=14) 
3.8x10
6
 + 0.4x10
6b
 
(n=12) 
5.3x10
6
 + 0.3x10
6c
 
(n= 6) 
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To assess the impact of hyper-stimulation with GnRH, male control and 
ERKdko animals were castrated or underwent a sham surgery and then euthanized 
after 7 days and serum concentrations of LH and FSH were measured. Again, 
consistent with control females, castration resulted in a marked increase in LH 
secretion compared to sham operated controls (Figure 5A). While castration resulted 
in a numerical increase in FSH in circulation, this change was not statistically 
significant (Figure 5B). Similar responses to castration on LH secretion were not 
evident in the ERKdko males (Figure 5A).  
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Figure 5: ERKdko males show blunted LH response to maximized endogenous 
GnRH stimulation post castration A) Control animals show a significant increase in 
serum LH concentration following castration. However, this response was blunted in 
ERKdko animals. B) Neither control nor ERKdko animals showed a statistically 
significant FSH increase in response to castration.  
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Males show premature reproductive aging, characterized by testicular dysplasia 
Control and ERKdko males were assessed at 6, 12, and 18 months of age for 
body weight, testis size, sperm count, and seminal vesicle weight (Table 3). By 12 and 
18 months of age, ERKdko animals had significantly lower sperm count and testis 
weight. Seminal vesicle weights in ERKdko animals were reduced in the 18 month 
group compared to controls. Aging related abnormalities were also evident in 
testicular histopathology (Figure 6). Testicular histology revealed evidence of 
testicular dysplasia in ERKdko animals at 18 months, but not in age matched control 
testes. The testes showed areas of marked testicular degeneration, calcification, 
aspermatic tubules and giant spermatid cells (Figure 6).  
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Figure 6: Aged ERKdko animals show loss of normal testicular histology. A) 
Testes of ERKdko animals showed grossly normal morphology until 18 months of 
age, where they display signs of testicular degeneration and dysplasia, such as 
calcification, aspermatic tubules, and giant spermatid cells. B) High magnification 
showing degeneration, calcification and loss of tubules.  
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The four signature gonadotrope gene transcript levels were assessed in pituitaries of 
males at 18 months of age. Neither control nor ERKdko animals showed significant 
changes in transcript levels within genotypes between 6 and 18 months. However, 
there was a significant decrease between Control and ERKdko animals at 18 months in 
LHβ, αGSU and GnRHR.(Figure 4D) Interestingly, we found no significant 
differences between genotypes or ages in circulating testosterone levels indicating that 
despite low levels of LH, these were sufficient to maintain testosterone levels in 
ERKdko males (data not shown). Serum LH and FSH assays were also performed. 
FSH levels were not significantly different between genotypes or ages at 6, 9, or 12 
months. However, aged ERKdko animals (18months) had a significant reduction in 
serum FSH, approximately a 3 fold decrease compared with 6 month animals and 
control animals at 18 months of age (Figure 7). 
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Figure 7: ERKdko animals showed a significant decrease in serum FSH at 18 
months of age (p<0.05).  
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Phenotype of aging ERKdko males is likely due to hypogonadotropism, not loss 
of testicular ERK signaling 
Other labs utilizing the GRIC Cre driver have reported Cre expression within 
the testes, specifically in the germ cell lineage.
19
 In order to parse out potential effects 
of gonadotrope-specific ERKdko versus lesions that might be attributable to loss of 
ERK signaling directly within the testes, we examined reporter activity in Rosa 26 
mice expressing a GRIC Cre allele using in situ β-galactosidase staining (Figure 8B). 
These studies supported the prediction from others that GRIC Cre activity is present 
within the testes but not the ovary.  
 To further understand the differential effects of ERK signaling in the pituitary 
and testes, we characterized aged males from a Stra8 Cre line on the same ERKdko 
background. Consistent with the GRIC-Cre driver, the Stra8 Cre driver is expressed in 
the spermatogonia, as well as in later stages of spermatogenesis.
38
 Analyzing testicular 
histology, as well as reproductive phenotype, of the Stra8 ERKdko males would allow 
us to understand whether the phenotype seen in the GRIC Cre ERKdko animals was 
specifically due to testicular or gonadotrope loss of ERK signaling. Histology of Stra8 
Cre ERKdko animals revealed minor degenerative changes at 18 months of age 
compared to control animals, consistent with the advanced age of the animals. By 
comparison, testicular degeneration was markedly more severe in the GRIC Cre 
ERKdko animals.(Figure 8C) Loss of ERK signaling in the Stra8 males showed a 
moderate decrease in sperm count, a severe decrease in litter size, but interestingly no 
significant change in testicular size, testes to body weight ratio, body weight or 
seminal gland weight compared to control animals. (Table3, Figure 8A) Aside from 
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the reduced sperm count, Stra8 ERKdko animals more strongly phenocopied the 
control animals than the GRIC ERKdko males, indicating the likelihood that the 
testicular degenerative phenotype seen in the GRIC ERKdko males was due to 
prolonged hypogonadotropism, not a direct effect of ERK signaling loss within the 
germ cell lineage of the testis. 
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Figure 8: Testicular degeneration in ERKdko animals is due to 
hypogonadotropism, not loss of testicular ERK A)Stra8 animals show significantly 
smaller litter sizes than control animals (7.1 versus 2 pups/litter). B) Both GRIC and 
STRA8 Rosa26 animals showed β- galactosidase expression in situ in the tubules of 
the testes. C) 18 month old Stra8 animals did not show the testicular degeneration seen 
in 18 month old ERKdko animals  
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DISCUSSION: 
Previous work in our lab has shown the role of ERK signaling within the 
pituitary is less essential to reproduction in males than in females; however, given the 
potential contributions of the thyrotrope lineage in these studies, the absolute role of 
ERK loss in the gonadotrope was unclear.
20
 We and others have attempted to 
understand the mechanisms and pathways involved in gonadotropin production using 
more specific gonadotrope Cre-mediated gene excision
19–21
. In the current studies, 
GRIC-mediated ERKdko animals of both sexes were hypogonadotropic, with a 
reduced response to endogenous GnRH stimulation. Both also showed reduced 
fertility at 6 months of age, with males being subfertile and females being infertile and 
anovulatory. We hypothesize this difference is due to the variation in LH and FSH 
requirements between males and females. In males, LH and FSH levels in ERKdko 
animals appear to be sufficient to maintain fertility, however, this is suboptimal. 
Females, on the other hand, have a notably more complex requirement for 
gonadotropins in reproduction, particularly in LH biosynthesis leading to the 
preovulatory surge and ovulation.
20
 Loss of ERK signaling in females precludes 
appropriate LH accumulation necessary for the LH surge. Although ERK signaling 
has been shown to be the primary pathway for gonadotropin biosynthesis, other 
signaling cascades have been proven to be able to create small amounts, which is 
likely how the ERKdko animals retain gonadotropin function. 
39–41
As the animals aged 
in this hypogonadotropic model, both sexes showed loss of normal gonadal histologic 
architecture, which was not seen in control aged animals or Stra8 Cre ERKdko aged 
males.  
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The requirement for pituitary ERK signaling in female mice in the present 
studies was generally similar to previous work done before in our lab by Bliss et al.
20
 
However, several points of comparison are noteworthy. The GRIC Cre excision 
appears to be exclusive to the pituitary gonadotrope, without expression in other 
pituitary cell lineages such as the thyrotrope
4
. Much like the αGSU Cre ERKdko 
animals, the loss of the ERK2 function in gonadotropes ablates the ability of female 
mice to produce a functional LH surge, capable of inducing ovulation. This was 
confirmed by the blunted LH serum levels in ERKdko females following castration. 
Interestingly, although FSH production was also blunted, females appeared to have 
similar numbers of follicles, including large antral follicles compared with control 
females suggesting that FSH levels were sufficient for normal ovarian 
folliculogenesis. As mentioned before, though the males also show blunted 
gonadotropin production in response to endogenous GnRH production, they only 
demonstrate moderate subfertility as young animals. There were some important 
differences between the models. The GRIC ERKdko females proceed through all 
phases of the estrous cycle, and are acyclic, instead of displaying anestrous similar to 
the αGSU females. One of the primary differences between the GSU and GRIC 
models of ERK deletion was in FSH production. Both males and female ERK 
deficient models, reduction in FSH transcript levels and secretion was more robust in 
the GRIC model. While the reasons behind this difference are not completely clear, 
this may be due to the timing of the onset of Cre recombinase activity and/or Cre 
penetrance. The αGSU was activated at e9.5, while the GRIC Cre is not active until 
e13.5.
42,43
 Multiple markers of pituitary and gonadotrope differentiation and function, 
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such as FGF, BMP4, BMP2, and the LIM homeodomain transcription factors, Isl1, 
Lhx3, and Lhx4, are expressed during that window, so loss of ERK in those cells could 
have broad impacts on pituitary lineage specification.
44
  
 Loss of ERK signaling, and subsequent hypogonadotropism caused age-related 
changes in gonadal histology, suggesting long term hypogonadotropism is detrimental 
to gonadal health and function. Females began showing abnormal ovarian histology at 
12 months of age, but the changes were not completely consistent with 
hypogonadotropism. Though they lacked CLs, one would expect a loss of mature 
follicles as the females aged, which was not seen.
30
 This was unsurprising, since the 
FSHβ levels were grossly unchanged from 6 months of age. Histology from young 
animals showed antral follicles as well, indicating sufficient FSH was present for 
follicle recruitment and maturation. By contrast, aged (18 month old) males displayed 
a severe reproductive phenotype including marked loss of sperm production, reduced 
testicular and seminal vesicle weight, as well as areas of moderate to severe testicular 
degeneration. This degeneration was localized to focal areas within the testis, not 
generalized throughout the testis. Interestingly, the testis weight and sperm count 
decreased between 6 and 12 months in males, but the decrease in seminal vesicle 
weight and the histological changes did not occur until 18 months of age. Although 
seminal vesicle weight is usually correlated with testosterone, it has been shown to 
have LH receptors, and the weight loss is likely associated with the precipitous drop in 
LH in 18 month old ERKdko males.
45
 At 18 months, males had only 22% of the sperm 
production seen at 6 months. While these males showed dramatic effects of testicular 
degeneration, it did not affect almost 80 percent of the tubules. This loss of sperm is 
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more than is expected with aging males in humans.
34
 Unlike human males, these mice 
did not show decreased testosterone with age. This is surprising, especially given the 
decrease in LH seen in the aged GRIC ERKdko males. In humans, blocking GnRH 
increases regularity of LH and testosterone secretion, as well as the feedback between 
them. However, age decreases these interactions, causing higher frequency of LH 
pulses, though lower pulse amplitude, and reduces the organization of the secretion of 
both hormones.
46,47
 Treating with GnRH seemed to correct the effects of aging, 
indicating the importance of an intact hypothalamic-pituitary relationship.
48
 Both male 
and female ERKdko animals showed increased body weight as they aged, likely due to 
decreased metabolic rate concomitant with loss of reproduction function. This is a well 
characterized phenomenon in human females during menopause, in castrated domestic 
animals, as well as in IHH patients
57–62
 
 We speculate that the phenotype seen in aged GRIC ERKdko animals is 
primarily due to hypogonadotropism, not hypogonadism or gonadal Cre excision. In 
female mice, there is no evidence the GRIC-Cre driver is expressed outside of the 
gonadotrope (except during pregnancy) suggesting that the anovulatory phenotype 
observed was due to hypogonadotropism. (Chapter III) Loss of gonadotropin 
production presumptively caused the absence of CLs, and studies in other chapters of 
this dissertation show that gonadotropin replacement is sufficient to induce ovulation 
and CL formation in ERKdko females. The histological degeneration within the ovary 
with increased age also appears to be due to the trophic effects of the gonadotropins 
and potentially secondary changes in ovarian steroids. Male ERKdko mice showed 
evidence of premature reproductive aging including a reduction in seminal vesicle 
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weight, and reduced testicular size. While we initially presumed this was associated 
with hypogonadism, testosterone levels were not significantly different between 
control and ERKdko animals suggesting either that the effects of ERK deletion might 
be local within the testes or that the reduced gonadotropins observed with the ERKdko 
males was sufficient to maintain testosterone production by Leydig cells.
49,50
  
ERKdko males also showed evidence of premature testicular degeneration, 
such as tubule vacuolation and calcification with increased age.
51,52
 These 
pathophysiological changes were not seen in littermate control males, and were 
apparently not associated with decreased testosterone levels.
53,54
 Since the GRIC Cre 
driver is expressed in the male germ cell lineage, we wanted to understand whether the 
histological effects we were observing were secondary to testicular ERK deletion or 
loss of gonadotrope cell trophic input to the testes. To assess this genetically, we 
developed a conditional ERKdko using the STRA8 Cre driver with specific ERK 
excision unique to the germ cell lineage, similar to the GRIC Cre driver. ERK 
deficiency induced by the STRA8 Cre driver did not phenocopy the GRIC ERKdko 
males suggesting that testicular degeneration was due to hypogonadtropism rather than 
a testicular loss of ERK signaling. This makes the GRIC ERKdko mouse an 
interesting model to study the specific effects of chronic hypogondotropism on the 
gonads with increasing age. This is not an area that has been well characterized in the 
literature in humans or model systems. IHH patients have been characterized with 
genetic deficiencies in GnRH production and/or secretion and treatment with GnRH or 
gonadotropins is a successful method to induce fertility and treat IHH in humans.
55,56
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Our mouse model responds appropriately to gonadotropins (Chapter XX), making 
them a potential model for treatment as well as the disease.  
.  
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CHAPTER 3 
 
 
 
 
 
 
 
 
Conditional loss of ERK1 and ERK2 results in abnormal placentation and 
delayed parturition in the mouse 
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ABSTRACT 
 
Extracellular-signal-regulated kinases (ERK) 1 and 2 regulate many aspects of 
the hypothalamic-pituitary-gonadal axis. We sought to understand the role of ERK1/2 
signaling in cells expressing the gonadotropin-releasing hormone receptor (GnRHR) 
using a conditional Cre allele regulated by the endogenous GnRHR gene promoter 
(ERK double knockout, or ERKdko). Previous studies demonstrate that female 
ERKdko mice were anovulatory. The present study examined if exogenous 
gonadotropins could rescue this phenotype, which lead to pregnancy in approximately 
one-third of the ERKdko females. Litters from ERKdko females were significantly 
smaller and pup weights at e18.5 were reduced, occurring coincident with prolonged 
gestation/parturition and 100% neonatal mortality. Interestingly, placental size was 
similar in control and ERKdko females indicating reduced placental efficiency. Based 
on this, we examined placental GnRHR expression during gestation in mouse 
implantation sites. GnRHR mRNA levels at e10.5 and e12.5 were comparable to 
pituitary GnRHR mRNA levels from adult female mice. Careful analyses of maternal 
decidua ate12.5 showed enrichment of GnRHR mRNA compared to the whole 
implantation site. Studies in Rosa26 reporter mice confirmed GRIC Cre activity, and 
ERKdko placentas showed reduced ERK2 protein levels. Histopathology revealed 
abnormalities in maternal vascular remodeling and architecture of the placental 
decidua (e18.5). Evidence of prominent regions of apoptosis at the decidual/uterine 
interface around the time of parturition (e18.5) was observed in control animals and 
reduced in ERKdko animals. These studies support a model of ERK-dependent 
signaling within the maternal decidua leading to loss of placental architecture, reduced 
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physiologic placental apoptosis necessary for placental detachment at parturition, and 
ultimately prolonged gestation and fetal mortality. 
 
INTRODUCTION: 
Mitogen-activated protein kinases (MAPKs) are signal transducing kinases that 
in general contribute to cell differentiation, survival and proliferation.
1,2
 MAPKs are a 
part of ubiquitous signaling cascades involving multiple intermediates associated with 
phospho-transfer including Raf-1 kinase, MEKK1, MEKs 1 and 2, and ERKs 1 and 2 
(MAPK3 and MAPK1, respectively).
3
 ERK1 and ERK2 have been long known to 
function integrally during embryonic development and in adult animals.
4,5
 ERK1 and 
ERK2 are believed to have divergent functions during development since ERK1 null 
mice are grossly viable and fertile while ERK 2 null mice are embryonic lethal.
6–8
 
Embryonic lethality of the ERK2 null mice appears to be strain-specific; some have 
reported evidence of failed early mesodermal differentiation while others report mis-
regulation of placental development.
9
 Both instances lead to early embryo mortality 
where ERK 1 does not appear to be compensatory. In adult animals, ERKs 1 and 2 
appear largely redundant helping to coordinate cellular responses to growth factors, 
peptide hormones and other ligands via a wide array of receptor subclasses controlling 
cell proliferation, differentiation and survival depending on the physiological context.  
Since ERK 2 null animals are embryonically lethal, a conditional approach to 
examining the specific role of ERK signaling in discrete cell types is necessary. In our 
original studies, we developed a pituitary specific conditional ERK double knockout 
using the ERK1 null and ERK2 floxed alleles combined with a Cre recombinase drive 
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regulated by the gene promoter for the  subunit to the glycoprotein hormones 
(GSU).3,10 These studies were instrumental in understanding the role and requirement 
for GnRH-induced ERK signaling to a cohort of immediate early response genes 
regulating gonadotropins in the pituitary. The resultant phenotype was female-specific 
anovulatory infertility due to a loss of LH subunit expression resulting in an inability 
to mount a preovulatory surge of LH. Further, we examined the specific role of Raf-1 
kinase in the regulation of GnRH-induced ERK activation finding that Raf-1 was 
dispensable for activation of this pathway. Similar studies of ERK double knockout 
conditionally in GnRH neurons did not impact fertility while loss of ERKs in the 
granulosa cell compartment revealed a requirement for ERK signaling in the ovarian 
follicle.
11
 Loss of LH-induced ERK activation in granulosa cells also resulted in 
infertility.
12
 Our original use of the GSU Cre driver was not without caveats, with 
GSU being expressed in thyrotropes and gonadotropes. The development of the 
GnRHR-IRES-Cre (GRIC) driver helped to resolve this caveat since Cre recombinase 
is knocked in to the endogenous GnRHR loci downstream of the GnRHR coding 
sequence.
13
 We have recently studied a similar ERK1/2 double knockout using the 
GRIC line examining the impact of this signaling loss in gonadotrope on male fertility 
and how these animals manage reproductive aging in a hypogonadal state (Chapter 2).  
In the present studies, we make use of conditional deletion of ERK 1 and 2 
using the GRIC driver to examine the hypothesis that these hypogonadotropic-
hypogonadal animals would respond to exogenous gonadotropins, ovulate and 
establish pregnancy. This question was of particular important since the GnRHR 
mRNA has been detected in tissues and cell types beyond the gonadotrope and GnRH 
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neurons including human trophoblast lineages and maternal decidua.
14,15
 However, it 
is presently unclear if Cre is expressed in these tissues in the GRIC model and if so, 
how specific loss of ERK signaling might impact pregnancy and parturition. GRIC-
ERKdko females were responsive to a standard superovulation paradigm with a subset 
of treated animals establishing and maintaining pregnancy without further 
gonadotropin therapy; however, gestation and parturition in these animals were 
markedly prolonged with all of the neonates dying before postnatal day 3. GRIC-
mediated gene excision was detected primarily in the maternal decidua and to a lesser 
extent in trophoblast cell populations later in gestation in the mouse. Loss of ERK 
signaling in this system resulted in dramatic histological changes in placental 
architecture, maternal artery remodeling and focal points of apoptosis normally 
associated with the initiation of parturition.  
 
MATERIALS and METHODS: 
ANIMALS  
 Animals were handled in compliance with the Cornell University Institutional 
Animal Care and Use Committee. ERK1 null (ERK1
-/-
), ERK2 floxed (ERK2
fl/fl
) and 
GnRH receptor IRES Cre (GRIC) mice have been described previously.
13,16,3
 To create 
gonadotrope specific ERK1/2 knockout animals, they were crossed and designated 
ERKdko (ERK1
-/-
, ERK2
fl/fl
, Cre
+/-
), or Control (ERK1
-/-
, ERK2
fl/fl
, Cre
-/-
). For 
experiments involving Cre visualization, ROSA26-GNZ KI mice were purchased from 
Jackson Laboratory These were crossed with GRIC animals, and designated ROSA26 
(GRIC
+/-
, ROSA
+/-
 or GRIC
+/+
, ROSA
+/+
). For timed matings, mice were paired and 
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checked for copulatory plugs daily. Pairs were separated after a copulatory plug was 
observed (embryonic day (e)0.5). On e10.5, e12.5 and e18.5, the dams were 
euthanized, and placentas were carefully dissected. For superovulation studies, 
females were injected with 100ug of pregnant mare serum gonadotropin (PMSG) 
intraperitoneally. 46-48 hours later, they were injected with 100ug human chorionic 
gonadotropin (hCG) intraperitoneally. For assessing CL and follicle formation, 
superovulated animals were euthanized 72 hours later, and ovaries were collected for 
histological examination. For induction of pregnancy, and assessment of parturition, 
superovulated control and ERKdko females were placed with a male and checked for 
copulatory plugs the following morning day. Following evidence of copulation, 
females were minimally handled until e18.5, at which point they were checked every 
12 hours. They were monitored for signs of initiation of parturition, contractions, 
distress, hiding, blood on the shavings, and pups. 
 
GENOTYPING 
 Genomic DNA was isolated from tail snips (3 mm), or an equivalent quantity 
of other tissues as indicated, using a E-Z Tissue DNA Kit (Omega Biotek, Norcross, 
GA) per manufacturer’s instructions. Routine PCR genotyping was performed on 
animals as previously described.
17
 PCR confirmation of ERK1 knockout, ERK2 flox, 
GnRHR Cre and Rosa alleles were performed with primers as listed below.  
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Primer 
 
Sequence (5’ to 3’) 
Rosa26 
Reporter 
Rosa26 Forward TAA GCC TGC CCA GAA GAC TC 
Rosa26 Reverse AAA GTC GCT CTG AGT TGT TAT 
Rosa26 Common 
TCC AGT TCA ACA TCA GCC GCT 
ACA 
ERK1 
ERK1 Forward AAG GTT AAC ATC CGG TCC AGC A 
ERK1 Reverse AAG CAA GGC TAA GCC GTA CC 
ERK2 
ERK2 Forward AGC CAA CAA TCC CAA CCC TG 
ERK2 Reverse GGC TGC AAC CAT CTC ACA AT 
GnRHR 
GnRHR Forward GAA CTA CAG CTG AAT CAG TC 
GnRHR Reverse CTC TAA CAA ACT CTG TAC A 
GnRHR 
Homozygous 
CGG AAT TCA TCG ATC ATA TCA 
GAT CC 
 
IMMUNOBLOTTING  
 Placentas were halved, with one half placed in formalin for histological studies 
or snap frozen for RNA analysis, and the other half homogenized in lysis buffer 
containing 20 mM Tris-HCl (pH 8.0), 130 mM NaCl, 10% glycerol, 1% Nonidet P-40, 
0.1% sodium dodecyl sulfate, 0.5% deoxycholate, 2mM EDTA, 5mM sodium 
vanadate, 0.2 mM phenylmethysulfonylfluoride, and 5 mM benzamidine. Protein 
concentrations of lysates were determined by Bradford assay. Samples were boiled for 
5 minutes in sodium dodecyl sulfate loading buffer, resolved by SDS-PAGE, and 
transferred to polyvinylidine difluoride membranes by electroblotting. Membranes 
were blocked with 5% nonfat dry milk in TBST (10 mM Tris-HCl, pH 7.5; 150mM 
NaCl; 0.05% Tween 20) and then incubated with specified antisera (anti-ERK2, anti-
βactin and horseradish peroxidase-conjugated secondary antibodies from Santa Cruz, 
Dallas, TX).
3
 Protein bands were visualized using enhanced chemiluminescence 
according to manufacturer’s instructions (BioRad, Berkeley, CA) and imaged on 
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ChemiDoc XRS (BioRad, Berkeley, CA) They were analyzed using Image Lab 
software (BioRad, Berkeley, CA). 
 
RNA ISOLATION AND QUANTITATIVE PCR 
Placentas were halved, and Trizol (ThermoFischer, Waltham, MA) extraction 
was performed per manufacturer’s instructions. Reverse transcription in 1000ng 
reactions was performed using the High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA) according to manufacturer directions. 
Amplifications were carried out using a BioRad CFX96 Touch Real-Time OCR 
Detection System (BioRad, Berkeley, CA). RNA levels were standardized using the 
internal control Gapdh and calibrated to corresponding transcript levels of a control 
group.
3
 
Primer  Sequence (5’ to 3’) 
Glyceraldehydes-3-
phosphate 
dehydrogenase 
Gapdh forward ATGTTTGTGATGGGTGTGAA 
Gapdh reverse ATGCCAAAGTTGTCATGGAT 
 GnRHR 
GnRHR forward TGCTCGGCCATCAACAACA 
GnRHR reverse GGCAGTAGAGAGTAGGAAAAGGA 
 
HISTOLOGY, IMMUNOFLUORESCENCE, and β-GALACTOSIDASE 
ASSAYS 
  Mice were paired and checked for copulatory plugs daily. Pairs were separated 
after a copulatory plug was observed (embryonic day (e)0.5). On e12.5 and e18.5, the 
dams were euthanized, and placentas were carefully dissected. For histological 
examination, tissues were fixed in 10% formalin, paraffin embedded, serially 
sectioned at 4µm, and stained with hematoxylin and eosin, terminal deoxynucleotidyl 
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transferase dUTP nick end labeling (TUNEL), isolectin or smooth muscle actin using 
standard histological techniques.
18
 Sections were examined with light microscopy. 
Sections were scanned and digitized using an Aperio Scanscope (Vista CA). Placenta 
area, area of decidua, junctional zone and labyrinth layers, along with luminal area of 
decidual vessels were quantitated using Aperio software. TUNEL was quantified using 
the Positive Pixel Algorithm on ImageScope (Leica Biosystems, Buffalo Grove, IL).  
For immunofluorescence labeling of GFP, placentas were embedded in Tissue-
Tek OCT media (Sakura Finetek, Torrence, CA) and maintained at -80°C in 2-
methylbutane for 24 hours. Sections (10µM) were cut using a cryotome and stored at -
80°C. Frozen sections were fixed with 4% paraformaldehyde, blocked for one hour, 
and stained with anti-GFP antibody (Abcam, Cambridge, United Kingdom) at 1:100 
overnight followed with a FITC goat-anti-rabbit secondary antibody (Vector 
Laboratories, Burlingame, CA). Sections were cover slipped with SlowFade Gold with 
DAPI (Life Technologies, Carlsbad, CA) and imaged on an AxioVision fluorescent 
microscope with Zen software (Zeiss, Oberkochen, Germany). Sections were also 
scanned and digitized using an Aperio Scanscope (Vista CA).  
For β-galactosidase in vitro assays, tissues were fixed in 4% 
paraformaldehyde/PBS for 1 hour at 4°C, then rinsed 3 times for 30 minutes each in a 
rinse buffer (100 mM sodium phosphate (pH 7.3), 2 mM MgCl2, 0.01% sodium 
deoxycholate, 0.02% NP-40 (by volume)). Sections were then stained overnight in 
staining buffer (rinse buffer with 5 mM potassium ferricyanide, 5 mM potassium 
ferrocyanide, 1 mg/ml X-gal). Sections were cleared using methyl salicylate, fixed 
overnight in 10% formalin, then washed with distilled water twice for 30 minutes. 
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They were dehydrated by sequential ethanol washes (70%, 95%, twice in 100%, then 
washed in methyl salicylate until the tissue cleared. 
For liquid β-Galactosidase Enzyme Assay System with Reporter Lysis Buffer 
(PROMEGA, Madison, WI) tissues were collected, and the assay was performed 
according to manufacturer’s instructions.  
 
STATISTICS 
Pairwise comparisons were made by Student's t-test. All data are expressed as 
means ± standard error of the mean. A p value of <0.05 was considered statistically 
significant. 
 
RESULTS: 
ERKdko animals can ovulate in response to exogenous gonadotropin stimulation.  
We previously reported a pituitary-specific conditional knockout of ERK1 and 
2 using the GSU Cre driver resulted in an anovulatory phenotype due to loss of LH 
biosynthesis.
3
 Those studies also characterized the ability of ERK deficient female 
mice to respond to exogenous gonadotropin stimulation and ovulate; however, we did 
not examine the possibility that gonadotropin stimulation and mating would lead to a 
viable pregnancy. We mated the ERK2
fl/fl
, ERK1
-/-
 animal with GRIC Cre animals to 
improve specificity of ERK ablation to the pituitary gonadotropes.
3,13
 In the present 
studies, these animals were designated ERKdko animals while control animals were 
designated ERK2
fl/fl
, ERK1
-/-
 , but Cre negative. Consistent with the GSU model 
system
3
, female ERKdko GRIC mice are infertile and anovulatory, with blunted 
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gonadotropin secretion in response to GnRH (Chapter 2). To better understand the 
gonadal response to exogenous gonadotropin stimulation in this model, female control 
and ERKdko animals were treated with either pregnant mare serum gonadotropin 
(PMSG) or a standard superovulation protocol of PMSG followed by administration 
of human chorionic gonadotropin (hCG) to induce ovulation.
19
 Three days later, 
control and ERKdko were euthanized and ovaries were collected and the number of 
antral follicles (AF) and corpora lutea (CL) were counted. As expected, addition of 
hCG in the superovulation paradigm resulted in the presence of CLs in both control 
and ERKdko females compared with PMSG alone (Figure 1A). No differences were 
detected in the number of antral follicles comparing control and ERKdko females 
receiving PMSG alone (Figure 1B). However, when treated with PMSG and followed 
by hCG, control animals had significantly more antral follicles compared to ERKdko 
animals (Figure 1 A, B). These data support the conclusion that the ERKdko females 
are fully capable of ovulation; however, due to the hypogonadotropic hypogonadism 
in this model, fewer ovarian follicles were stimulated by the superovulation paradigm. 
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Figure 1: ERKdko females respond appropriately to exogenous gonadotropin 
stimulation. A) Photomicrographs of ovaries from Control and ERKdko female mice. 
Both genotypes responded to gonadotropin administration. B) Fewer antral follicles 
were seen in ERKdko animals compared to Control with PMSG administration 
(p=.093). Following PMSG and hCG administration, ERKdko animals had 
significantly fewer antral follicles (1.6) when compared to control (4). There were no 
changes in the number of CL’s present between genotypes, following either treatment. 
The treatments were successful, as ERKdko animals are incapable of making CL’s 
without hCG stimulation.  
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ERKdko animals can maintain pregnancy, but show prolonged gestation and 
parturition 
 We next asked whether superovulated ERKdko females could establish and 
maintain a pregnancy to term with viable pups in the absence of ERK signaling within 
the gonadotrope. Control and ERKdko females were induced to ovulate, mated to 
control males and copulatory plugs were observed. Control and ERKdko females with 
a copulatory plug were allowed to proceed through gestation. Beginning at 19 days 
following detection of a copulatory plug, females were observed visually every 12 
hours and assessed for signs of parturition (hiding, contractions, and visible distress) 
or the presence of pups. All control and approximately 70 percent of ERKdko animals 
exhibited a copulatory plug after superovulation and were paired with fertile 
experienced males. Control animals gave birth normally around gestational day 20; 
however, ERKdko females did not give birth until nearly gestational day 24 (p<0.05; 
Table 1). In control females, parturition was complete within a 12 hour period; while 
ERKdko females showed continuous signs of labor for 2.3 days (p<0.05; Table 1) 
suggesting the possibility of abnormal parturition or dystocia. Finally, control animals 
had an average of 9 pups/litter; while litter size in the ERKdko females was 2.4 
pups/litter (p<0.05; Table 1) consistent with reduced antral follicle populations in the 
ERKdko females. Pups from ERKdko females were stillborn or died soon after birth; 
the percentage of live pups from the ERKdko females was zero compared with 85.7% 
in the control females (p<0.05; Table 1).  
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Table 1: Female ERKdko mice showed alterations in gestation and parturition, 
resulting in fetal mortality 
 Litter size (# 
of pups)  
% live pups 
on PN3  
Gestation 
length (d)  
Parturition 
length (d)  
  Control  9.0 + 1
a
 
(n=6) 
85.7 + 11.7
a
 
(n=3)  
20.3 + 0.25
a
 
(n=5)  
1.0 + 0.0
a
 
(n=4)  
ERKdko  2.4 + 1.3
b
 
(n=7)  
0
b
 
(n=7)  
23.9 + 0.55
b
 
(n=4)  
2.3 + 0.42
b
 
(n=4)  
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GnRHR is preferentially expressed in the placental decidua  
Perusal of the literature revealed reports of normal pups routinely born to 
wildtype females after superovulation protocols. This suggests administration of 
gonadotropins to induce ovulation was not likely a cause of prolonged gestation and 
fetal demise in our model system.
19–22
 Moreover, while ERKdko animals have been 
shown to display defects in gonadotropin production, no evidence in the literature 
directly links hypogonadotropism to delayed parturition and periparturient fetal 
mortality.
23–26
 We considered that the abnormal pregnancies may be a consequence of 
expression of Cre activity and subsequent loss of ERK signaling potential in the 
placenta, as GnRH and GnRHR have been detected in the placenta and decidua of 
several species.
14,27–30
 
We used qRT-PCR to detect GnRHR mRNA in placentas of embryonic (e)10.5 
and e12.5 mice and compared this directly with female pituitaries at estrus. Levels of 
GnRHR in the whole placental disk were similar to levels of GnRHR found in adult 
female pituitaries at estrus (Figure 2). To further validate these observations, we used 
the Rosa26 reporter mouse line mated to GRIC
+
 males. In this model, Cre-mediated 
gene excision results in expression of a β-galactosidase (gal)-green fluorescent protein 
(GFP) fusion protein. In-situ β-gal staining of whole mouse pituitaries and placental 
disks confirmed the presence of β-gal activity within both tissues (Figure3A-C). The 
highest density of -gal activity was found at the periphery of the placental disk, 
indicating enrichment within the maternal decidua (Figure 3B). Using placental tissues 
from ROSA26 control- and GRIC-mated animals obtained at e12.5, we then carried 
out an in vitro β-galactosidase assay to quantify relative β-gal expression in a cross 
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section of tissues. We compared GRIC
-
 and GRIC
+
 placental tissues along with GRIC
+
 
pituitary, hypothalamus, ovary, pancreas, liver and muscle from the same animals. 
Placenta lysates from ROSA26/GRIC
+
 animals revealed fourfold increase (P<0.05) of 
β-galactosidase activity compared with the Rosa26 animals without Cre expression. 
Interestingly, the placentas from ROSA26/GRIC
+
 animals also had higher (p<0.05) β-
gal activity compared with pituitaries from the same animals (midgestation female 
mice; Figure 3D).  
After establishing Cre expression in placentas using the Rosa26 reporter mice, 
we examined localization of expression within the placental disks to better understand 
the results of ERK2 loss. E12.5 placentas were dissected to carefully separate the 
decidua from the remainder of the placental disk including the chorionic plate and 
labyrinth. RNA was extracted and qRT-PCR was performed, allowing us to quantify 
enrichment of the GnRHR mRNA in the decidua versus remainder of the disk. 
GnRHR mRNA was more abundantly expressed in the maternal decidua compared to 
the remainder of the placenta disk (Figure 2E).  
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Figure 2: qRT-PCR was performed on placental disks from embryonic days 10.5 and 
12.5. Levels of GnRHR were comparable with those seen in adult female pituitaries 
collected at estrus
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Figure 3: A) Adult Rosa26
+
Cre
+
 female pituitary of stained for β-galactosidase in situ. 
β-gal staining indicates the presence of Cre activity. B) Placenta from e18.5 
Rosa26
+
Cre
+
 embryo, showing β-gal staining (indicative of Cre activity) in situ. C) 
Placenta from e18.5 Rosa26
-
Cre
-
 embryo, showing no autologous in situ β-gal staining 
. D) Liquid β-galactosidase assay confirmed Cre activity in Rosa26+Cre+ pituitaries 
and placentas, but baseline activity in Cre
-
 tissues (muscle, liver, pancreas) (p<0.05). 
E) qRT-PCR showed significant GnRHR mRNA expression in placental decidual 
lysates when compared to whole disk lysates (p<0.05). This indicates preferential 
expression of GnRHR and the associated Cre in the decidual compartments, instead of 
the entire placenta.  
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GnRHR is expressed throughout the placenta at e12.5 and preferentially in the 
labyrinth at e18.5 
 Rosa26 animals were time mated, and euthanized at e12.5 and e18.5. Placentas 
were collected, snap frozen, serial sectioned and stained for GFP expression. At e 
12.5, GnRHR-GFP appears to be expressed throughout the placenta, but most strongly 
in the maternal decidua (Figure 4A). Punctate GnRHR expression surrounds nuclei in 
clusters of cell within the decidua. There is mild expression of GnRHR throughout cell 
cytoplasm of the labyrinth, but no areas of punctate expression were seen (Figure 4B).  
 At e18.5, the punctate expression seen in the decidua is no longer observed; 
however, the labyrinth showed marked up regulation of GnRHR expression when 
compared to e12.5 (Figure 4A,B). Larger foci of GFP expression are observed around 
the cell surface, and it additionally appears to be diffusely expressed throughout the 
cytoplasm (Figure 4B). Negative control showed decreased expression of both 
cytoplasmic and cell surface GnRHR. (Figure 4B) 
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Figure 4:Localization of GnRHR-GFP in the placenta at e12.5, e18.5 A) GRIC-
Rosa placentas at e12.5, stained for GFP. There is staining through out the placenta, 
but strongest around the periphery of the decidua and in clusters of punctate staining 
throughout the decidua and into the junctional zone. The labyrinth had lower basal 
staining, but lacked any punctate perinuclear expression. B) Rosa placentas at e18.5, 
stained for GFP. There is expression in the decidua and labyrinth, with focal areas of 
strong expression throughout the labyrinth. All sections are stained for DAPI. 
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GRIC Cre expression results in loss of placental ERK2  
Western blot analyses added additional confirmation of Cre-mediated ERK 
gene deletion (Figure 5). We specifically assayed for the abundance of ERK2 since 
our genetic model is ERK1
-/-
. For the remainder of the characterization, we separated 
the animals into three categories: control dam, control pup (control/control), ERKdko 
dam, control pup (ERKdko/control), and ERKdko dam, ERKdko pup 
(ERKdko/ERKdko). We observed ~30% reduction of ERK 2 protein levels in 
placentas from both ERKdko groups when compared to placentas from control dams 
(Figure 5). This suggests the genotype of the dam has a more significant impact on 
placental ERK expression than the genotype of the pup, again consistent with GnRHR 
localization and subsequent loss of ERK2 in maternal decidua.  
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Figure 5: A) Western blotting revealed loss of ERK2 expression in placental lysates 
in both control and ERKdko pups from ERKdko dams. This indicates functional Cre 
activity, excising the floxed ERK2 locus. B) Quantitation of ERK 2 protein levels 
show significant (p <0.05) decrease of ERK2 protein expression in placentas from 
ERKdko dams, regardless of fetal genotype. This again indicates preferential 
expression of the Cre in the maternal derived placental compartment (decidua) when 
compared to the fetal derived placental compartment (labyrinth).  
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Loss of ERK2 in decidua results in gross and histological abnormalities in the  
placental disk 
 
ERKdko and control animals were superovulated, mated, and euthanized at 
e18.5. Anecdotally, all pups from the ERKdko (and control) dams showed evidence of 
fetal viablity at this gestational age. ERKdko/Control and ERKdko/ERKdko pups 
displayed reduced fetal weight at e18.5 compared to control pups (p<0.05; Figure 6A). 
Consistent with earlier studies on ERK2 expression levels, reduced pup weight was 
accounted for by loss of ERKs within the decidua (maternal ERKdko). Intrauterine 
growth restriction seen in ERKdko/ERKdko pups could not be accounted for by 
changes in placental weight (Figure 6B) indicating that the fetal growth restriction 
observed was due to loss of relative placental efficiency, not placental size. Gross 
morphology of the placental disks revealed that ERKdko/ERKdko placentas appeared 
hemorrhagic with congested decidua and grossly exaggerated labyrinth compared to 
control/control placentas (Figure 6C, D). 
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Figure 6: A, B) e18.5 Control (left) and ERKdko/ERKdko placenta. The ERKdko 
placenta appears grossly congested and discolored. C) Pups from ERKdko dams, 
regardless of fetal genotype, are significantly smaller (p <0.05) than those from 
Control dams at e18.5. This indicates a potential IUGR, and again confirms the 
importance of the Cre activity in the maternal compartment of the placenta, regardless 
of fetal Cre status. D) Despite changes in pup weight, placental disk weight was 
unaffected by maternal or fetal genotype, indicating loss of placental efficiency, 
instead of loss of placental mass or cellularity. 
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Gross placental findings described above were consistent with histological 
assessment of these placentas at e18.5 (Figure 7). For these studies, placentas were 
dissected free from the uterine wall, fixed in formalin, then sectioned and stained with 
hematoxylin and eosin. Pups from ERKdko dams had abnormal placental architecture 
regardless of fetal genotype (Figure 7). Pathological findings indicated that placentas 
from ERKdko dams and control fetuses appeared histologically disorganized 
compared to control placentas. These placentas displayed variability in decidual 
thickness within a placenta, with increased mitotic index in trophoblast cells 
suggesting increased proliferation rate. These findings were not consistent with 
neoplastic changes, but more aligned with exuberant tissue growth. The trophoblast 
cytoplasm showed grossly increased vacuolation and a mild unusual cystic 
development. There were also fingerlike projections of the junctional zone into the 
labyrinth. Loss of ERK signaling resulted in the appearance of large acellular spaces 
within the junctional zone and increased numbers of large vacuolated cells. These 
findings were further exacerbated in the ERKdko/ERKdko placentas, with more 
severe cystic changes, especially in the decidua and junctional zone, consistent with a 
more robust disorganization of the normal placental architecture seen in the 
control/control placentas.  
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Figure 7: Photomicrographs of representative placentas from control/control, 
ERKdko/control and ERKdko/ERKdko dam/pup pairs, stained for isolectin. Loss of 
ERK2 results in vacuolation of the junctional zone, with loss of normal placental 
architecture and invaginations of the junctional zone into the labyrinth compartment. 
The ERKdko placentas showed cystic development and higher rates of mitotic figures, 
consistent with increased proliferation. To the right are insets showing increased 
magnification of areas of cystic development, vacuolation and projection into the 
labyrinth area.  
  
151 
 
 
 
  
152 
 
 Figure 8A depicts the distribution of area of the labyrinth, junctional zone and 
decidua which again varied with genotype. Using Aperio image analysis software,  
placentas from control dams and control pups were characterized by approximately 49 
percent labyrinth, 26 percent junctional zone, and 17 percent decidua (with the 
remainder of the area attributed to chorionic plate). Placentas of ERkdko dams and 
ERKdko pups showed a significantly enlarged labyrinth area and a smaller decidual 
area (Figure 8A), compared to the control animals. Placentas from ERKdko dams and 
control pups showed an intermediate phenotype that was not significantly different 
from either of the other two genotypes (data not shown). Junctional zone areas did not 
significantly vary between any of the genotypes. As these zones all have variations in 
functions and vasculature, we next assessed changes in placental vascularization 
between genotypes. 
 
Histological changes in the placenta occur coincident with placental vasculature 
abnormalities 
Changes in placental vasculature have long been associated with placental 
pathology and disease states.
31–34
 We approached our assessment of the vasculature in 
two ways; isolectin staining to examine endothelial cell density and specific analyses 
of maternal arteries using smooth muscle actin staining in decidua. Staining tissues 
sections with isolectin (conjugated to Nova red) highlights the extracellular matrix of 
endothelial cells, allowing visualization of highly vascularized regions such as the 
labyrinth, junctional zone and the decidua.
35
 Both the number of isolectin positive 
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cells and the intensity of isolectin staining was blunted (p<0.05) in ERKdko/ERKdko 
placentas in both the decidua and junctional zone compared to control (Figure 8B,C). 
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Figure 8: A) ERKdko/ERKdko placentas show significantly smaller decidual zones 
and increased relative labyrinth area when compared to Control/Control placentas (p < 
0.05). B) Isolectin stained cells, highlighting endothelial cells, were significantly 
decreased in the maternal decidual and junctional zone compartments in 
ERKdko/ERKdko placentas, when compared to Control/Control placentas. There was 
no increase in isolectin staining in the fetal labyrinth compartment. C) Isolectin stain 
intensity was decreased in both the decidual and junctional zone compartments in 
ERKdko/ERKdko animals when compared to Control/Control animals. (p <0.05). This 
indicates loss of endothelial cell in these compartments, likely secondary to loss of 
ERK2 signaling.  
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 To assess specific changes in maternal vasculature remodeling within the 
decidua, E18.5 placental sections were stained for smooth muscle actin to reveal the 
size and location of maternal arteries in the placenta. Each artery identified was 
confirmed with the presence of non-nucleated erythrocytes in the lumen of the vessels, 
as previously described.
18
 ERKdko/ERKdko and ERKdko/control placentas had 
approximately 50% fewer maternal arteries in the decidua than the placentas of 
control/control pups (p<0.05; Figure 9A, B). Of the arteries present, the intraluminal 
area of maternal vessels in the ERKdko/ERKdko placentas were approximately 60 
percent smaller, than those in control/control placentas. There was no significant 
difference between intraluminal area of ERKdko/control placentas and either of the 
two other groups due to high variation in artery size (data not shown).  
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Figure 9: A) Photomicrograph showing loss of ERK2 in maternal decidua 
compartment results in smaller decidual spiral arteries in ERKdko/ERKdko placentas 
when compared to Control animals. B) ERKdko ERKdko placentas also show fewer 
maternal decidual arteries when compared to placentas from Control animals (p<0.05) 
C) ERKdko ERKdko placentas have significantly smaller artery lumens when 
compared to Control placentas (p <0.05, n = 23 arteries for Control, 26 
Control/ERKdko, 30 ERKdko/ERKdko). 
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Loss of ERK2 signaling in the placenta causes decreased parturition-associated 
apoptosis 
E18.5 placentas were stained with TUNEL to examine apoptosis. As expected, 
control/control placentas showed focal areas of apoptosis at the interface of the 
decidua and uterus, allowing for separation of the maternal/placental unit during 
parturition.
36–39
 ERKdko/control placentas had a smaller area of TUNEL positive cells 
around the edges of the decidua. The ERKdko/ERKdko placentas had reduced 
TUNEL positive staining around the edges of the decidua, indicating a loss of 
physiologic apoptosis associated with parturition (Figure 10A). Total placental 
TUNEL staining was reduced in ERKdko/ERKdko animals by nearly 25% (p<0.05, 
Figure 9B). Interestingly, most of this appeared to be localized to the periphery of the 
decidua. Control/control placentas showed positive TUNEL staining in approximately 
17 percent of the decidua, while ERKdko/ERKdko animals showed only 9 percent of 
the decidua to be positive for TUNEL staining at e18.5 (p<0.05, Figure 10C). TUNEL 
staining in placentas from ERKdko/control pups were not significantly different than 
either of the other two groups (data not shown). The loss of pro-apoptotic tone in 
ERKdko/ERKdko placentas correlates with prolonged gestation and delayed 
parturition, indicating lack of readiness to begin parturition at e18.5 in these animals.  
 
  
160 
 
Figure 10: A) Photomicrographs showing TUNEL positive staining, indicating 
apoptosis of placental decidua. B) Control animals showed approximately 17 percent 
of decidua beginning apoptosis, indicating the initiation of the events preceding 
parturition. ERKdko ERKdko animals showed significantly less TUNEL staining, 
with only approximately 9 percent of the decidua affected (p <0.05, n=5 
placentas/genotype). C) Quantifying the entire placenta for TUNEL staining showed a 
modest reduction in overall apoptotic tone in Control/Control placentas, when 
compared to ERKdko/ERKdko placentas (p<0.05).  
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DISCUSSION: 
While ERK loss has long been shown to be detrimental to the function of the 
hypothalamic-pituitary-gonadal axis as well as the placenta, this is the first report of a 
novel model of placental ERK deletion associated with expression of the GnRHR in a 
mouse.
3,13
 In the present studies, loss of pituitary gonadotropin production in the 
GRIC-ERKdko model was overcome through exogenous gonadotropin administration 
consistent with a standard superovulation protocol, allowing ERKdko animals to 
ovulate and become pregnant. The resulting pregnancy in ERKdko/ERKdko females 
was abnormal, characterized by prolonged gestation and parturition, and 100% fetal 
mortality. GnRHR-mediated Cre expression, and subsequent ERK excision was 
documented within the placenta. The loss of ERK signaling within the placenta also 
revealed abnormal developmental morphology of the decidua and junctional zones, 
characterized by an expanded labyrinth, reduced decidua, and reduced endothelial 
isolectin expression in the decidua and junctional zones. ERKdko placentas also 
showed reduced maternal decidual artery size and number. These placentas showed a 
significant reduction in physiologic apoptosis necessary for placental separation prior 
to parturition, consistent with the prolonged gestation phenotype observed. 
Collectively, these studies shed new light on the role of ERK signaling within the 
placenta in the mouse. 
GnRHR has been localized in the placenta of multiple species, including 
humans and canines. In humans, GnRHR, GnRH I and GnRH II are expressed in the 
first trimester of human pregnancy, and regulate both trophoblast invasion and hCG 
secretion. GnRHR localizes to the cytotrophoblasts and extravillous trophoblasts 
  
163 
 
(EVT) of the placenta, but less in the syncytiotrophoblasts.
40
 GnRH I and II localize to 
mononucleate villous, and EVTs, but GnRH I is also found in the multinucleated 
syncytial trophoblast layer in the chorionic villi during the first trimester of pregnancy. 
Interestingly, only GnRH I was found in the placenta at term.
41
 Recently, GnRHR has 
been described in the canine placenta as well. Similar to the human, GnRHR was 
expressed at higher levels in the uteroplacental tissues than in the areas of the uterus 
less associated with the placenta (i.e., between implantation sites in this litter bearing 
species). In the canine placenta, GnRHR was found in fetal trophoblasts and maternal 
decidual cells, and at the surface and glandular epithelial cells in the uterus.
28
 Again, 
this indicates the strong association with GnRHR and the maternal fetal interface in 
the placenta. Our studies provide a novel view of these expression profiles and the 
utility of the GRIC model to direct gene excision to these compartments.  
 GnRH and GnRHR regulate gene expression and gonadotropin secretion in the 
placenta.
42
 This occurs through protein kinase A and C pathways, and can be blocked 
using inhibition of GnRH.
43,44
 Treatment with GnRH or an analog has been shown to 
increase placental GnRHR mRNA and causes phosphorylation of PKC, ERK1/2, and 
JNK.
27,43,44
 Activation of transcription factors increases in GnRHR transcription and 
hCG secretion indicates that GnRH is an important regulator of placental function, 
potentially acting in both paracrine and autocrine fashions.
45
 Although human and rat 
pregnancy is affected by local placental and systemic hCG or LH secretion, 
respectively, no evidence exists for gonadotropin regulation of murine 
pregnancy.
14,23,26,46–49
 This indicates the phenotype described above is likely due to 
loss of ERK2 signaling in the placenta, potentially affect secreted factors that regulate 
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placental morphogenesis and or vascularization. Other studies have shown that loss of 
ERK2 in the null animals causes catastrophic defects in the mouse placenta, so 
understanding the function of ERK signaling in a specific subset of placental cells is 
very informative.
50
 
Loss of placental ERK2 resulted in reduced vascularization, expression of 
isolectins within the endothelial compartment, and placental abnormalities that may 
have contributed to reduced fetal weight in the current studies. We speculate that 
expression of GnRHR (and Cre) and subsequent loss of ERK signaling during the 
formation of the decidua prior to e12.5 is a likely cause of the changes in placental 
histology seen at e18.5.
51
 Either the change in architecture or loss of ERK2 signaling 
could impact EVT invasion and subsequent maternal spiral artery remodeling, 
reducing the number and intraluminal areas of arteries seen in the decidua.
44
 
Additionally, matrix metalloproteases, which are also regulated by GnRH/GnRHR in 
the placenta, are involved in maternal spiral artery remodeling, leading to another 
hypothesis for reduced decidual vascularization; however, the specific role of ERK 
signaling in this situation is not clear.
44,52
 Reduction of endothelial cell populations or 
function in the decidua and junctional zone likely reduces placental transfer and 
efficiency between mother and fetus. This results in reduction of fetal size and may 
account for reduction in litter size if the loss of ERK signaling at the maternal/fetal 
interface caused placental insufficiency. Loss of normal placental architecture, large 
cystic areas, general disorganization of the decidua and junctional zone, along with 
reduction in vascular tone could result in loss of efficient nutrient exchange between 
the fetus and dam, resulting in a fetal IUGR and possibly fetal distress/death. 
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Prolonged gestation and parturition stem from loss of placental ERK 2 and 
causes periparturient mortality in pups. Multiple factors initiate parturition, including 
fetal cortisol, maternal drop in progesterone, oxytocin, prostaglandin F2α and other 
endocrine facotrs.
53–56
 Loss of either maternal or fetal ERK-dependent inputs could 
cause failure to initiate or sustain parturition, as seen in this model. This loss may stem 
from reduction in signaling between dam and fetus due to loss of vascular reduction or 
placental abnormalities. Hypogonadism in the ERKdko mice may also cause a 
reduction in baseline progesterone due to losses of LH support to the ovary. (Chapter 
2) Progesterone withdrawal is a contributing factor to initiation of parturition and the 
possibility exists that the baseline reduction in progesterone in our model system does 
not occur at a level to initiate parturition.
57
 Loss of ERK signaling in GnRHR 
expressing cells may ostensibly blunt or abrogate the release of PGF2α, thus 
contributing the delayed onset of parturition.
58
 Alterations in oxytocin release is likely 
not related to the delayed parturition since this peptide is not implicated as an 
important factor in the onset of parturition in mice.
59
 The loss of TUNEL staining at 
e18.5 indicates that ERKdko animals are not undergoing normal changes within the 
placenta in preparation for parturition. This indicates loss of some sort of signal to 
initiate focal apoptosis at the uterine/decidual interface. Future studies will need to 
focus on specific contribution of ERK signaling within the maternal fetal interface to 
determine the precise mechanisms involved. 
The GRIC model holds interesting potential as a model of human disease. 
GnRHR has been shown to be important in placental development and function; it is 
even expressed at the implantation sites of ectopic pregnancy.
40
 Although multiple 
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mouse models have been used to recapitulate idiopathic hypogonadal hypogonadism 
(IHH), none have focused on loss of function in cells expressing GnRHR and how 
ERK signaling may be functioning in these tissue compartments.
3,16,60
 Up to 40 
percent of IHH patients suffer from a GnRHR mutation, which could alter placental 
function as well.
61
 Work by Janet Hall’s lab has indicated that although some women 
with IHH respond appropriately to gonadotropin supplementation and are able to carry 
a normal pregnancy, others are not.
62,63
 Some of these women suffer from multiple 
miscarriages, most often early in gestation. Not all patients with these mutations 
showed early pregnancy losses, indicating a non-genetic component, such as 
alterations in placental function as a contributing factor.
62,64,65
 Further investigation of 
this model system may elucidate missing links and help improve assisted reproduction 
in women with IHH.  
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CHAPTER 4 
 
 
 
 
 
 
 
 
GnRH induces ERK-dependent expression of the bile acid receptor TGR5 in the 
pituitary gonadotrope 
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ABSTRACT 
ERK1/2 regulates reproduction in multiple parts of the hypothalamic-pituitary-gonadal 
(HPG) axis. Previously, our lab has shown ERK1/2 signaling to be integral to pituitary 
gonadotrope function. To identify novel downstream targets of GnRH and ERK1/2, 
we performed RNA sequencing on pituitaries with and without GnRH stimulation. 
These unbiased screens revealed a novel relationship between a G-protein-coupled 
receptor (GPCR), TGR5, ERK1/2 and GnRH signaling. TGR5 is a bile acid receptor 
that regulates metabolic signaling including glucose homeostasis. Treatment with 
GnRH increased TGR5 mRNA at both one and four hours post stimulation, which was 
lost with conditional loss of gonadotrope ERK1/2 signaling. This finding was 
validated in in vivo mouse models, as well as in vitro cell culture systems. Cholic acid 
(a hydrophilic bile acid) stimulation of αT3-1 cells induced CREB phosphorylation. 
Primary pituitary cultures treated with GnRH, cholic acid (CA) or a TGR5 agonist 
(INT777) all induced secretion of LH. TGR5ko mice are mildly subfertile compared to 
control animals. Loss of TGR5 resulted in delayed puberty, prolonged estrus cycles, 
smaller litters at longer inter-litter intervals, lower uterine and ovarian weights, and 
had lower levels of gonadotropin subunit mRNAs. In control animals, pituitary TGR5 
mRNA varied based on estrus cycle stage, and superovulation with INT777 caused 
ovarian luteal formation, indicating TGR5 agonists can drive an ovulatory LH surge. 
These studies indicate TGR5 is a modulator of the HPG axis. A known regulator of 
metabolism, TGR5 shows promise as a link between obesity, metabolic disorders, and 
reproduction, including issues of alterations in onset of puberty. 
.  
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INTRODUCTION 
Work from our lab, and many others, has established the role of ERK1/2 
signaling in the HPG axis, and specifically the pituitary.
1–4
 Both Bliss et al, and 
research reported earlier in this dissertation, highlight the specific role of ERK in the 
pituitary gonadotrope (Chapter 2).
1
 Briefly, loss of ERK signaling reduces or 
eliminates gonadotropin production in females, leading to infertility due to 
anovulation (Chapter 2). The mitogen activated protein kinase (MAPK) cascade is 
well established upstream of ERK1/2. 
5–8
 This kinase cascade activates immediate 
early genes, such as c-Fos, c-Jun and Egr1 and is an integral regulator of many 
biological processes, such as LH secretion, meiosis and placental formation.
9–13
 Due to 
ERKs ubiquitous expression, ERK signaling is likely involved in regulating 
reproduction through unknown mechanisms as well as those already discovered.
13–16
 
To help elucidate some of these mechanisms in the pituitary, we utilized the GRIC 
mouse. The GRIC mouse (GnRH Receptor IRES Cre) allows gonadotrope specific 
excision of a target gene. We combined this mouse with an ERK1
-/-
, ERK
f/f
 mouse, to 
excise ERK2 specifically in the gonadotrope. We then conducted an unbiased screen 
to identify novel targets of GnRH stimulation that are ERK dependent.
17,18
  
 While a plethora of targets were identified through this screen, a few stood out 
as exceptionally intriguing. One of these targets, which was GnRH responsive and 
ERK dependent, was a bile acid receptor, TGR5, also known as GP-BAR1. This G-
Protein coupled receptor (GPCR) was first identified in 2002, and has since been 
characterized as a regulator of metabolism.
19,20
 TGR5 shows over 80 percent 
homology between multiple species, including humans and rodents.
21
 This receptor is 
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preferentially activated by hydrophobic bile acids, and shows greatest response to 
taurine-conjugated lithocholic acid (TLCA), followed by lithocholic acid (LCA), 
deoxycholic acid (DCA), chenodeoxycholic acid (CDCA) and cholic acid (CA).
20
 
Interestingly, several steroid hormones have shown activation of TGR5, including 
pregnandione.
20
 It has been localized to multiple hepatic cell types, specifically 
sinusoidal endothelial cells and Kupffer cells, as well as the pancreas, macrophages, 
the gallbladder, the gastrointestinal tract, enteric nervous system, brown adipose 
tissue, muscles and others.
21–24
 As expected for a widely expressed receptor, TGR5 
has multiple functions. Primarily, it was recognized for its role in the gallbladder, 
promoting bile production, gallbladder filling, and smooth muscle relaxation.
25
 It 
serves protective functions against hepatocellular carcinoma and cholestatic injury in 
the liver.
21,23
 This protection is likely secondary to one of its other known effects; 
TGR5 reduces inflammatory reactions. Activation of TGR5 suppresses NF-κB 
phosphorylation and binding activity, inhibits macrophage reactivity and cytokine 
production, including tumor-necrosis factor α, IL-1α, IL-1β, and IL-6.21,26–29 TGR5 
activation increases metabolism and energy expenditure, without increasing activity or 
decreasing food intake.
21
 Activation of TGR5 also increases glucose tolerance and 
intracellular ATP/ADP ratio. These effects are suspected to be secondary to an 
increase in glucagon-like peptide (GLP)-1 stimulation, which up regulates liver and 
pancreatic function.
24,30
 Bile acid signaling through TGR5 also activates 2-
iodothyronine deiodinase, which converts inactive thyroxine (T4) to tri-iodothyronine 
(T3), which is biologically active.
20,31–33
 The improvement in metabolism following 
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bariatric surgery is hypothesized to be a function of increased bile acids and TGR5 
stimulation.
34
 
 TGR5 has also been implicated in reproduction. Both bile acids and TGR5 
were found in the testes, ovary and adrenals. Taurocholic acid (TCA), and CA were 
identified in all three tissues, while DCA was only found in the testis and ovary.
35
 
Most of the characterization of the impact of bile acids on reproduction has been done 
in males, specifically focusing on testicular effects. Males fed a diet supplemented 
with 0.5% cholic acid showed reduced fertility, characterized by rupture of the blood-
testes barrier, increased spermatid apoptosis, germ cell sloughing, and reduced 
testosterone. These effects are likely due to bile acid activation of TGR5 signaling in 
the germ cells and farnesoid receptor 1 (FXR) signaling in the Leydig cells.
36,37
 
Similar symptoms were seen in male mice suffering from obesity and metabolic 
syndrome when treated with bile acids.
38
 Finally, bile acids and their receptors have 
been implicated in puberty. Male rats who underwent a bile duct ligation prior to 
puberty had alterations in liver size and liver enzymes, but also had smaller testes and 
seminal vesicle size, indicating a defect in normal pubertal maturation.
39
 Multiple 
other labs have shown alterations in the bile pool around puberty in both humans and 
mice.
40–42
 In humans, females bile acid pools displayed greater changes than males 
during puberty.
42
 Since the bile acid pool is responsive to hormonal changes during 
puberty, it seems logical that the pool may be affected by other changes in the 
hormonal milieu, like pregnancy.
43
  
 We investigated the function of the bile acid receptor TGR5 in the pituitary, 
and its role in reproduction, focusing on female mice. These studies show that TGR5 
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is not only expressed in the pituitary, but plays an active role in reproduction and 
when activated, is capable of inducing gonadotropin production. Loss of TGR5 causes 
minor reproductive deficits in female mice. These studies indicate that TGR5 is a 
functional link between reproduction and metabolism, and may be implicated in the 
link between delayed puberty and obesity or as a mechanism related to diabetic or 
obesity related infertility.  
 
MATERIALS AND METHODS 
ANIMALS 
ERK1 null (ERK1
-/-
), ERK2 floxed (ERK2
fl/fl
) and GRIC mice have been 
described previously.
1,17,44
 To create gonadotrope specific ERK1/2 knockout animals, 
they were crossed and designated ERKdko (ERK1
-/-
, ERK2
fl/fl
, Cre
+/-
), or Control 
(ERK1
-/-
, ERK2
fl/fl
, Cre
-/-
). TGR5 Knockout, TGR5
-/-
, (TGR5ko) animals were the 
generous gift of the Dr. Kristina Schoonjans and the Auwerx lab and have been 
described previously.
27,45
 Animals were handled in compliance with the Cornell 
University Institutional Animal Care and Use Committee. 
Female TGR5ko and control animals were checked every 24 hours after 
weaning (day 21) for evidence of vaginal opening as previously described.
46
 Inter-
litter interval and litter size was collected from data from harem bred animals over an 
8 month period. For all experiments, animals were humanely euthanized via CO2 
asphyxiation, and blood, pituitaries, hypothalamus, ovaries, uterus, and liver were 
collected. Uterus and ovaries were carefully dissected from the surrounding fat, and 
weighed. Hypothalamus, pituitary, one ovary, half of the uterus, and a small amount of 
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liver were snap frozen. The remaining uterus and ovary were fixed overnight in 10 
percent formalin. 
 
GENOTYPING 
Genomic DNA was isolated from tail snips (3 mm), or an equivalent quantity 
of other tissues as indicated, using a E-Z Tissue DNA Kit (Omega Biotek, Norcross, 
GA) per manufacturer’s instructions. Routine PCR genotyping was performed on 
animals as previously described.
47
 PCR confirmation of ERK1 knockout, ERK2 flox, 
GnRHR cre, and TGR5ko were performed, with primers as listed below.  
Primer Sequence (5’ to 3’) 
TGR5 KO 
TGR5 rec GAT GGC TGA GAG GCG AAG 
TGR5 Common AGA GCC AAG AGG GAC AAT CC 
TGR5 Wildtype TGG GTG AGT GGA GTC TTC CT 
ERK1 
ERK1 Forward AAG GTT AAC ATC CGG TCC AGC A 
ERK1 Reverse AAG CAA GGC TAA GCC GTA CC 
ERK2 
ERK2 Forward AGC CAA CAA TCC CAA CCC TG 
ERK2 Reverse GGC TGC AAC CAT CTC ACA AT 
GnRHR 
GnRHR Forward GAA CTA CAG CTG AAT CAG TC 
GnRHR Reverse CTC TAA CAA ACT CTG TAC A 
GnRHR Homozygous 
CGG AAT TCA TCG ATC ATA TCA GAT 
CC 
 
RNA Sequencing Screen 
 To assess changes in the transcriptome regulated by GnRH and ERK signaling, 
adult female control and ERKdko mice were passively immunized against endogenous 
GnRH using a sheep anti-GnRH antiserum (generously provided by Dr. Terry Nett, 
Colorado State University) as previously reported.
48
 Three days following passive 
immunization, animals received saline or dAla6-GnRH, an analog of GnRH not bound 
by the passive immunoneutralization. Animals were euthanized at time 0, 1, and 4 
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hours following dAla6-GnRH administration. Pituitaries were dissected free and 
pituitary RNA was isolated using Triazol (ThermoFischer, Waltham, MA) per the 
manufacturer’s instructions. RNA samples (n = 3/genotype/treatment) were sent to the 
Weill Cornell Genomics and Epigenomics Core facility for library preparation and 
sequencing on a HiSeq 2000. The data were analyzed through a previously described 
computational pipeline and differentially expressed genes were analyzed using 
network analysis databases Reactome and KEGG.
49,50
 
 
RNA ISOLATION AND QUANTITATIVE PCR 
Tissues were collected and Trizol (ThermoFischer, Waltham, MA) extraction 
was performed per manufacturer’s instructions. Reverse transcription in 1000ug 
reactions was performed using the High-Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Foster City, CA) according to manufacturer directions. qRTPCR 
was performed using SYBRGREEN (ThermoFisher, Waltham, MA) and primers 
listed below. They were run on a BioRad CFX96 Touch Real-Time OCR Detection 
System (BioRad, Berkeley, CA).  
Primer Sequence (5’ to 3’) 
Glyceraldehydes-3-
phosphate 
dehydrogenase 
Gapdh forward ATGTTTGTGATGGGTGTGAA 
Gapdh reverse ATGCCAAAGTTGTCATGGAT 
Gonadotropin 
Releasing Hormone 
Receptor 
GnRHR 
forward 
TGCTCGGCCATCAACAACA 
GnRHR reverse GGCAGTAGAGAGTAGGAAAAGGA 
Luteinizing Hormone 
β-subunit 
LHβ forward CTGAGCCCAAGTGTGGTGTG 
LHβ reverse GACCATGCTAGGACAGTAGCC 
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Follicle Stimulating 
Hormone β-subunit 
FSHβ forward GCCATAGCTGTGAATTGACCA 
FSHβ reverse AGATCCCTAGTGTAGCAGTAGC 
α-Glycoprotein 
Subunit 
α-GSU forward TCCAGGGCATATCCCACTCC 
α-GSU reverse CATTTCCCATTACTGTGGCCTTA 
TGR5 
TGR5 forward GCTCCTGTCAGTCTTGGCCTAT 
TGR5 reverse TTCCTCGAAGCACTCGTAGACA 
Farnesoid receptor 1 
FXR forward CGA AGA CTC CCT CAC AGT TG 
FXR reverse ACC TCT ACT TCA TCT CCT TCA CT 
 
SUBCELLULAR MEMBRANE RAFT FRACTIONATION 
 Membrane raft fractions were isolated from T3-1 cells and whole mouse 
pituitaries as described previously.
18,51,52
 Briefly, T3-1 cells and whole mouse 
pituitaries were lysed in a buffer containing low concentrations of non-ionic detergents 
and membranes were subjected to centrifugation in a discontinuous sucrose gradient. 
Low buoyant density membrane fractions were identified using the marker Flotillin 1 
and compared to non-raft fractions of higher density. In some studies, membrane 
fractions (low and high density) were subjected to digestion with PNGaseF to cleave 
glycosylation moieties. The digested membrane samples were resolved by SDS PAGE 
and probed with antibodies directed against TGR5.  
 
IMMUNOBLOTTING 
 Cells were homogenized in lysis buffer containing 20 mM Tris-HCl (pH 8.0), 
130 mM NaCl, 10% glycerol, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, 0.5% 
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deoxycholate, 2mM EDTA, 5mM sodium vanadate, 0.2 mM 
phenylmethysulfonylfluoride, and 5 mM benzamidine. Protein concentrations were 
determined by Bradford assay. PNGase F treatment was performed according to 
manufacturer’s instructions (New England Biolabs, Ipswitch, MA). Samples were 
boiled for 5 minutes in sodium dodecyl sulfate load buffer, resolved by SDS-PAGE, 
and transferred to polyvinylidine difluoride membranes by electroblotting. Membranes 
were blocked with 5% nonfat dry milk in TBST (10 mM Tris-HCl, pH 7.5; 150mM 
NaCl; 0.05% Tween 20) and then incubated with specified antisera (anti-TGR5, 
Abcam, Cambridge, UK; anti-CREB, anti-pCREB, Millipore, Billerica, MA; anti-
Flotillin-1, BD, Franklin Lakes, NY; horseradish peroxidase-conjugated secondary 
antibodies from Bio-Rad, Hercules, CA).
1
 Protein bands were visualized using 
enhanced chemiluminescence according to manufacturer’s instructions (BioRad, 
Berkeley, CA) and imaged on ChemiDoc XRS (BioRad, Berkeley, CA) They were 
analyzed using Image Lab software (BioRad, Berkeley, CA). 
 
CELL CULTURE 
αT3–1 cells, an immortalized mouse gonadotrope cell line (generously 
provided by Dr Pamela Mellon, University of California, San Diego, CA), were 
cultured as described previously.
53,54
 αT3–1 cells were maintained in DMEM 
containing 2mM glutamine, 100-U penicillin/mL, 100µg streptomycin/mL, 1x 
nonessential amino acids, 10% fetal bovine serum. Cells were grown in 5% CO2 in air 
at 37°C in a humidified environment. Buserelin (des-GLY10 [D-Ser(t-But)6]-LH-RH 
ethylamide; referred to as GnRHa) was obtained from Phoenix Pharmaceuticals Ltd. 
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All other chemicals were obtained from Sigma. In all experiments, GnRHa was used 
at 10nM. Cholic acid was dissolved in DMSO and used at 1, 10, and 100µM 
concentrations. INT-777 was used at 10uM, and GW4064 was used at 1, 10, and 
100µM. Cells treated with U0126 (Promega), a MEK inhibitor, were incubated for 30 
minutes prior to other treatment. 
 
PITUITARY PRIMARY CULTURE 
Primary pituitary culture was performed as previously described.
52
 Pituitaries 
were subjected to collagenase digestion (1.5 mg/mL) with periodic trituration using a 
sterile Pasteur pipette. The dispersed cells were transferred to complete media, 
pelleted, and resuspended. They were aliquoted to 24-well plates pretreated with poly 
L-lysine at a density of approximately 750,000 cells/well. Primary pituitary cells were 
incubated in complete media at 37°C in a humidified atmosphere (5% CO2, 95% O2) 
overnight. The following day, the cells were gently washed in serum-free DMEM for 
2 hours. The cells were treated with buserelin, cholic acid, INT777 or GW4064. The 
media was harvested 4 hours later and assayed for LH. The pituitary cells remaining in 
the wells were lysed to assay for total protein using the Bradford assay. 
Concentrations of LH were determined using a commercially available ELISA per the 
manufacturer’s instructions (Genway Biotechnology), and LH concentration was 
standardized by protein content of the specific wells. 
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SUPEROVULATION 
Females were injected with 5 IU of pregnant mare serum gonadotropin 
(PMSG) intraperitoneally. 46-48 hours later, they were injected with either 5IU human 
chorionic gonadotropin (hCG), 0.1ml of saline, or 30mg/kg of INT777 
intraperitoneally. For assessing CL and follicle formation, they were humanely 
euthanized 72 hours later, and ovaries were collected for histological examination.  
 
HISTOLOGY 
For histological examination, tissues were fixed in 10% formalin, paraffin 
embedded, serially sectioned at 4µm, and stained with hematoxylin and eosin using 
standard histological techniques. For characterization of the ovarian follicular 
population, every third section was examined microscopically for identification of 
follicular and luteal tissue. For post-superovulation, ovaries were step-sectioned at 
20µm and examined for identification of luteal tissue. Sections were scanned and 
digitized using an Aperio Scanscope (Vista, CA). 
 
VAGINAL CYTOLOGY 
The vaginal vault was swabbed, which was used to make a cytological smear. 
It was stained with Wright’s Giemsa stain, and examined with light microscopy. 
Epithelial cells, parabasal cells and leukocytes were differentiated on the basis of 
morphology. An animal was deemed to be in estrus with >85% superficial epithelial 
cells. Estrus interval was calculated as the days from the onset of estrus until the onset 
of the subsequent estrus. 
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STATISTICS 
Comparisons were made by Student's t-test. All data are expressed as means ± 
standard error of the mean. A p value of <0.05 was considered statistically significant. 
 
RESULTS 
Unbiased RNA sequencing screen revealed the presence of bile acid receptors as 
a target of GnRH action in the gonadotrope 
GnRH action and signaling via ERKs 1 and 2 are required for fertility in 
female mice
1
 (see Chapter 2 in this dissertation). In the absence of ERKs in the 
gonadotrope (ERKdko), female mice display hypogonadotropic hypogonadism and 
anovulatory infertility. To gain more mechanistic insight into how GnRH-inducible, 
ERK dependent signaling controls gonadotrope cell function, we performed an 
RNAseq screen in mice receiving carefully timed administration of GnRH. For these 
studies, control and ERKdko female mice were immunoneutralized against GnRH. 
They were injected with either vehicle or dAla6-GnRH, and euthanized after either 1 
or 4 hours. Pituitaries were collected and submitted for RNA sequencing. Data sets 
were analyzed for differential mRNA expression. Differentially expressed genes were 
then subjected to KEGG and Reactome network analyses to determine 
interrelationships between groups of differentially expressed transcripts (Figure 1 and 
Tables 1 and 2). Network analyses revealed transcript changes within a cohort of 
GPCRs at the 1 and 4 hour time points. This cohort of genes suggested that several 
GPCRs were GnRH inducible and required ERK signaling for up-regulation at either 1 
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or 4 hours following dAla6-GnRH administration. Table 2 identified Gpbar1 (G-
protein membrane bile acid receptor)/TGR5 as a GPCR robustly regulated by GnRH in 
an ERK signaling dependent manner. 
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Figure 1: Strategy for preparation of RNA sequencing samples. Animals were 
immunoneutralized against GnRH. We waited three days, then treated them with 
dAla
6
 or saline, and were euthanized at 0,1, or 4 hours after treatment.  
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Table 1. Outcome from network analysis of RNAseq data set emphasizing signaling 
via GPCRs. (NS=non-significant) 
Reactome gene 
networks  
ERKdko vs 
Control  
(p value @ T0)  
ERKdko vs 
Control  
(p value @ 1 h) 
ERKdko vs 
Control  
(p value @ 4 h) 
GPCR 
Downstream 
Signaling 
NS NS
 
 0.00021
 
 
GPCR Ligand 
Binding  
NS 0.097
 
 0.00085
 
 
Signaling by 
GPCRs 
NS 0.045 0.0016 
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Table 2. Changes in Gpbar1/TGR5 mRNA levels following 1 and 4 hours of GnRH 
treatment comparing control and ERKdko female mice. (NS=non-significant) 
Transcript 
ERKdko  vs 
Control  
(log fold @ 0 h)  
ERKdko  vs 
Control  
(log fold @ 1 h)  
ERKdko  vs 
Control  
(log fold @ 4 h)  
Gpbar1/ 
TGR5 
NS -5.11 
(p = 0.027) 
-7.51 
(p = 0.001) 
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Bile acid receptors are expressed in multiple tissues in the hypothalamic-
pituitary-gonadal axis 
Given the surprising finding that TGR5 was expressed and regulated within the 
gonadotrope, we next sought to determine the expression profile of TGR5 and an 
additional bile acid receptor within the reproductive axis. To accomplished this, we 
obtained TGR5 null mice (a generous gift from Dr. Kristina Schoonjans, IFPL) to 
better confirm expression profiles. Pituitary, hypothalamus, uterus, ovaries, testes and 
liver were collected from wild type and TGR5ko animals and were assessed for TGR5 
and farnesoid X receptor (FXR) mRNA abundance (Figure 2). TGR5 was found at 
highest levels in the liver of wildtype animals, but was also detected in male and 
female pituitaries, testes, uterus and ovaries. TGR5 was below the detectable limits in 
tissues from TGR5ko animals and the preoptic area of the hypothalamus (Figure 2A). 
FXR was found at high levels in both male and female pituitaries, ovaries, and 
hypothalamus. Highest levels of FXR were found in the testes, and it was found at 
similar levels to TGR5 in the liver (Figure 2B). These studies revealed the 
comprehensive expression of bile acid receptors within the reproductive axis. We next 
focused on potential mechanisms that bile acid signaling may influence within this 
endocrine axis initially focusing on the gonadotrope since this was the original tissue 
investigated in our RNA screen.  
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Figure 2: Identification of tissues expressing TGR5 transcripts. Dotted line represents 
the lower detectable limit of the assay. A) TGR5 is expressed in pituitaries of both 
male and female mice, as well as the testes, ovaries, uterus and liver. It was not 
expressed in the pituitary or liver of TGR5ko mice, or in the hypothalamus. B) FXR is 
expressed in the male and female pituitaries, in both wildtype and TGR5ko mice. It is 
also expressed in the testes in very high levels, as well as the ovary and hypothalamus. 
It is not expressed in the uterus.  
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TGR5 is GnRH responsive and ERK1/2 dependent in pituitary gonadotropes 
TGR5 mRNA was induced strongly at one and 4 hours following GnRH 
administration; this regulation was negated with deletion of ERK1/2 signaling in the 
pituitary gonadotropes (Table 2). Using the immortalized pituitary gonadotrope cell 
line, αT3-1 cells, these results were validated. GnRHa (buserelin) treatment for four 
hours caused significant upregulation of TGR5 mRNA in these cells. This increase 
was completely ablated with the addition of U0126, a MEK inhibitor (Figure 3A). 
Confirmation that TGR5 was GnRH responsive and ERK dependent in vitro caused us 
to investigate whether TGR5 protein was absent in pituitary in the ERKdko model in 
vivo (Chapter 2). Pituitaries were collected, and subjected to membrane raft 
fractionation to more clearly examine membrane localization of TGR5. Membrane 
fractions were subjected to immunoblotting for TGR5 in both high and low density 
fractions from discontinuous sucrose gradients. TGR5 was detected in the high and 
low density fraction of control animals, but was not seen in any membrane fractions of 
ERK1/2 knockout animals, confirming the importance of ERK signaling in TGR5 
regulation (Figure 3B). Flotillin 1 was used as a marker of membrane raft 
fractionation. 
The observation that TGR5 was localized to low buoyant density fractions in 
whole mouse pituitary prompted us to examine the membrane localization of this 
GPCR in more detail in T3-1 cells (Figure 3A). Membrane raft fractions were 
resolved using SDS PAGE and immunoblotted with the TGR5 antibody. In some 
fractions, digestion with PNGaseF (a deglycosylase) was used to determine membrane 
localization of TGR5 as a function of TGR5 glycosylation state. In mock digested 
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fractions, TGR5 was detected as 95 kDa, 68 kDa and 35 kDa bands in high buoyant 
density membrane fractions, presumably reflecting variation in glycosylation state of 
the receptor. In low buoyant density raft fractions, the 68 kDa band was enriched 
while the 95 kDa and 35 kDa bands were reduced. PNGaseF treatment resulted in 
detection of the 35 kDa band in the raft fractions supporting speculation that in 
membrane rafts, only the glycosylated form of TGR5 was present (Figure 3C).  
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Figure 3: In vitro and in vivo verification of RNA sequencing results A) αT3-1 cells 
show significant increase in TGR5 transcript levels after 4 hours of treatment with 
GnRHa. This increase was negated with pretreatment with the MEK inhibitor U0126. 
B) TGR5 western blot of membrane raft fractions from pituitaries of control and 
ERKdko mice. ERKdko mice lacked TGR5 expression in the pituitary. C) TGR5 
expression in membrane raft fractions from αT3-1 cells. In low density fractions, 
TGR5 appears to be preferentially glycosylated, while in high density, non-raft 
fractions, TGR5 exists in both glycosylated and nonglycosylated states  
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TGR5 is functionally active in pituitary gonadotrope cells in vitro 
After confirming the presence and GnRH/ERK regulation of TGR5 in the 
pituitary, we sought to determine the functional activity of the receptor, initially 
utilizing αT3-1 cells. Cells were treated with vehicle, a TGR5 agonist, cholic acid , or 
a GnRH agonist, buserelin , for 15 minutes. Cells were collected and lysates were 
immunoblotted for cAMP response element binding protein (CREB), or 
phophorylated-CREB (pCREB). At 15 minutes of stimulation, both cholic acid and 
buserelin induced CREB phosphorylation consistent with the observations of others, 
indicating TGR5 is likely coupled to adenylyl cyclase (Figure 4A).
55,56
 These studies 
supported the conclusion that TGR5 is functionally active in an in vitro gonadotrope 
cell model.  
To confirm that TGR5 is functionally active in fully differentiated gonadotrope 
cells, male and female control mice were euthanized and pituitaries were collected. 
Pituitaries were dispersed into primary culture and plated overnight. The cells were 
then treated with either buserelin , cholic acid , the TGR5 agonist INT777 , or the FXR 
agonist, GW4064. Media was collected after 4 hours of treatment, and LH 
concentrations in the media were determined.  
Primary culture from male animals showed LH secretion following GnRH 
stimulation, as well as cholic acid and INT777 stimulation. There was no LH 
production following Gw4064 stimulation (data not shown). Interestingly, females 
showed much lower LH response to Cholic acid and INT777 stimulation than males, 
but still showed no LH production from GW4064 (Figure 4B, C). Together, this data 
indicate that not only does TGR5 have a functional role in phosphorylation of CREB 
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in pituitary gonadotropes, it also plays a potentially important physiological role in the 
regulation of LH secretion. Stimulation of pituitary cells with TGR5 agonists causes 
LH secretion, though the threshold and response appears to vary between males and 
females. Interestingly, although FXR does appear to be present in the pituitary, it does 
not appear to be functional, as treatment with FXR agonist did not induce LH 
secretion. 
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Figure 4: Pituitary TGR5 expression has functional significance A) Immunoblot 
showing CREB phosphorylation after treatment with GnRH and cholic acid. Total 
CREB shown as lane loading control. B) Primary pituitary culture treated with cholic 
acid (100µM) or GnRHa (10nM), buserelin, showed increased LH production 
compared with vehicle treated cells. C) Primary pituitary culture showed greater 
sensitivity to the specific TGR5 agonist INT-777 than cholic acid, secreting more LH 
in response to a lower concentration (10µM)  
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TGR5 alters gonadotropin transcript level and secretion  
Following our observations that TGR5 agonists could incite gonadotropin 
secretion in vitro, we assessed the in vivo effects of bile acid stimulation on 
gonadotropin secretion. Wildtype C57/B6 animals were treated with pregnant mare 
serum gonadotropin (PMSG), followed by either saline, INT777, or human chorionic 
gonadotropin (hCG) 46 hours later. We speculated that since INT777 and cholic acid 
could induce LH secretion in vitro, this treatment might induce ovulation in PMSG-
treated mice. Ovaries were collected 72 hours after the second treatment, serially 
sectioned and assessed for the presence of corpora lutea. Luteal tissue was observed in 
both ovaries from PMSG/hCG and PMSG/INT777 treated animals, but it was not seen 
in PMSG/saline treated animals. This indicates that treatment INT777, a TGR5 
agonist, can initiate an LH surge capable of inducing ovulation and subsequent CL 
formation in female mice (Figure 5). 
  
207 
 
Figure 5: Treatment with INT-777 as part of a superovulation protocol induces 
ovulation. Control female mice were given PMSG (FSH agonist), then either saline 
(negative control), hCG (LH agonist) or INT-777 (TGR5 agonist) 48 hours later. 
Ovaries were collected 72 hours following the second injection, and assessed for 
follicular and luteal structures. A) Animals in the saline group showed no luteal 
formation, but displayed large antral follicles, an indication they did not ovulate, as 
expected. B) Animals in the hCG group showed multiple CL’s in each ovary, 
indicating successful induction of ovulation. C) Animals treated with INT-777 showed 
a mix of CLs and antral follicles, indicating that INT-777 is capable of producing an 
LH surge commensurate with that needed for ovulation.  
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Since a TGR5 agonist was capable of inducing gonadotropin production, we 
assessed baseline gonadotrope function in control and TGR5ko animals. Females of 
both genotypes were followed through the estrous cycle via vaginal cytology, and 
euthanized at proestrus. Pituitaries were extracted, and assessed for transcript levels of 
signature gonadotrope genes (GnRHR, FSHβ, and LHβ). GnRHR and LHβ were 
significantly reduced in TGR5ko animals compared to control animals at estrus 
(p<0.05). There was a trend towards FSHβ transcript reduction, (p<0.1), which was 
likely associated with small sample size and individual variation. (Figure 6) 
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Figure 6: TGR5ko animals display blunted gonadotropin subunit transcript 
levels. TGR5ko females display about 20 percent lower levels of GnRHR, 
approximately a 30 percent decrease in Lhβ levels (p<0.05 for both). There was an 
approximately 50 percent reduction in FSHβ transcript levels, but this was not 
significant (p<0.1), due to high variability and small sample size.  
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TGR5ko mice show mild subfertility 
 Blunted gonadotrope transcript levels in TGR5ko animals lead us to assess 
them for a reproductive phenotype. While these animals are fertile, they display 
notable deficits in their reproductive capacity. Initially, TGR5ko females displayed a 
mildly prolonged inter-estrus interval, 4.1 days in controls compared to 6.7 days in 
TGR5ko animals (Figure 7B). The prolonged estrus interval may have contributed to a 
nearly 50 percent prolonged inter-litter interval in TGR5ko animals as well (Figure 
7C). TGR5 transcript levels appeared to vary in the female pituitary throughout the 
estrous cycle; reaching a nadir at diestrus and a significantly higher level at estrus 
(Figure 7D). As TGR5 stimulation causes gonadotropin release (Figures 4, 5), loss of 
TGR5 in the pituitary during estrus could alter the hormonal milieu significantly 
enough to reduce the reproductive capacity of TGR5ko mice, as indicated above. 
There was no significant difference in body weights between TGR5ko and wildtype 
animals (data not shown). 
  
213 
 
Figure 7: Female TGR5ko animals show reduced reproductive characteristics A) 
TGR5ko animals had an approximately 4 day delay in vaginal opening (day 25.2 
versus day 28.8) B) TGR5ko animals had a significantly inter-estrus interval of 5.5 
days, compared to 4.7 days in control animals. C) They also displayed a longer 
interval between litters, with an average of 45 days, while control animals had a litter 
on average every 33 days. D) TGR5 showed significantly higher expression of 
transcript levels during estrus than diestrus. For all panels, p<0.05.  
  
214 
 
 
  
215 
 
TGR5 transcript levels are altered with puberty 
 Bile acid pools have been shown to be altered during puberty, and conversely 
changes in bile acid metabolism can impact the onset of puberty and fertility in rats.
39–
42
 TGR5 transcript levels were assessed in the pituitary and liver of control mice 
before, during and post-puberty. Liver TGR5 transcript levels remained below 
detectable levels until after puberty. In the pituitary, TGR5 mRNA levels decreased 
from pre-pubertal (post natal day 18) levels during puberty, but increased three fold 
above pn18 levels after puberty (Figure 8A, B). This indicates that changes in TGR5 
transcript levels during puberty are likely related to either changes in GnRH signaling 
or alterations in metabolism and bile acid pool that occur during puberty. Confirming 
physiologic importance of TGR5 in puberty onset, female TGR5ko mice displayed 
delayed puberty, by about 4 days, as assessed by day of vaginal opening (Figure 7A). 
This was independent of body weight (data not shown). 
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Figure 8: TGR5 transcript expression varies throughout puberty A) TGR5 
transcript expression in the pituitary of control animals decreases from pn18 through 
puberty (pn25, 30) and increases significantly by adulthood. B) TGR5 transcript levels 
in the liver remain under the detectable limit of the assay until pn30, as defined by the 
level found in tissues from TGR5ko animals. This level increases significantly after 
puberty (>pn50).  
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TGR5ko females show evidence of reduced HPG axis function 
Coincident with changes previously characterized, female TGR5ko mice 
showed evidence of reduced gonadotropin and steroid hormone levels. They had a 30 
percent reduction in uterine weight, and a nearly 50 percent reduction in ovarian 
weight, which can be associated with a decrease in estradiol levels (Figure 9B, C). The 
reduction in ovarian weight is likely due to loss of normal ovarian structures and 
activity; the TGR5ko females showed significantly fewer antral follicles (Figure 9D), 
which is consistent with the reduction of FSHβ transcript levels (Figure 6). The 
reduction in follicle count, in turn, appeared to lead to significantly smaller litters 
(Figure 9A).  
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Figure 9: TGR5ko females show evidence of reduced gonadotropin and steroid 
hormone function. A) TGR5ko females have an average of 5.1 pups per litter, while 
control animals have an average of 7.4, significantly more. B) They also an 
approximately 30 percent decrease in uterine wet weight (average of 72mg), compared 
to control animals (average 109mg). C) Ovarian weight in TGR5ko animals was also 
significantly reduced at 5.0mg, compared to 6.5mg in control animals. D) Finally, 
TGR5ko animals displayed fewer antral follicles (4.0) than control animals (5.6). For 
all data in this figure, p<0.05.  
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DISCUSSION  
TGR5, a GPCR bile acid receptor, is known to have roles in inflammation, 
liver and biliary disease, gastrointestinal physiology, and fertility.
21,57,58
 An unbiased 
RNA sequencing screen found hypophyseal TGR5 to be GnRH responsive in an ERK 
dependent manner. This was confirmed in vitro and in vivo. TGR5 transcript 
expression was seen in the pituitary and the gonads. Activation of TGR5 by either the 
endogenous ligand, cholic acid, or a synthetic, specific TGR5 agonist, INT777, 
induced CREB phosphorylation in αT3-1 cells, and LH secretion in primary pituitary 
cells. It also induced ovulation in female mice as part of a superovulation protocol.  
 In vivo, TGR5ko females had reduced transcript levels of gonadotrope specific 
genes, GnRHR, LHβ and FSHβ. They also showed delayed puberty, prolonged estrus 
cycles, and had smaller litters at longer intervals. They displayed reduced ovarian and 
uterine weights, and had fewer antral follicles. Interestingly, TGR5 levels in the 
pituitary seemed to vary throughout the estrus cycle; they were significantly higher in 
estrus than in diestrus, indicating hormonal regulation of TGR5. Corroborating this 
hypothesis of hormonal regulation of bile acid signaling, pituitary TGR5 transcript 
levels fluctuate significantly throughout puberty. These findings add to our 
understanding of TGR5, and provide evidence it can act as a functional modulator of 
female reproduction.  
 To our knowledge, this is the first time a bile acid receptor has been implicated 
in gonadotropin production. Our studies show that bile acid stimulation causes LH 
secretion in pituitary primary culture, but bile acids can also cause a significant 
enough LH surge to induce ovulation and formation of corpora lutea in mice. The bile 
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acid pool changes with changes in steroid hormone milieu, such as pregnancy, 
indicating at least responsiveness to hormone concentrations. We know treatment with 
bile acids can induce LH production; so conversely, female TGR5ko animals may 
have reductions or alterations in LH synthesis and release. These changes could 
account for the reproductive deficits seen in those animals. Unfortunately, due to assay 
limitations, we do not know if bile acid treatment causes induction of FSH as well. 
Reduction of FSH would lead to the reduced antral follicles. Reduction in 
gonadotropin levels has been associated with reduction in litter size, estrus interval, 
ovarian and uterine weight (Chapter 2). Further evidence GnRH and gonadotropin 
signaling modulate TGR5 expression is demonstrated by the upregulation of TGR5 
transcript levels during estrus. This could be due to induction by GnRH signaling. 
With an increase in TGR5, similar bile acid levels are likely to result in an increased 
signaling response and could contribute to the LH surge. In humans, the total amount 
of bile acids in enterohepatic circulation is known as the bile acid pool. The 
composition of this pool can vary, altering the percentage of the different types of bile 
acids.
59
 Although the size of this pool doesn’t alter throughout the menstrual cycle in 
humans, alterations in the composition could increase the activation of TGR5. 
Alternately, receptor upregulation could cause an increase in TGR5 signaling, without 
a change in the pool size. 
43
 
Supplementing male mice with cholic acid caused infertility, germ cell 
apoptosis and decreases in testosterone. These changes appear to be mediated through 
both TGR5 and FXR, via CAR, SHP, and Dax1 signaling.
38,60
 TGR5ko males did not 
show these phenotypes when supplemented with CA.
36
 Contrarily, our data indicates 
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that loss of TGR5 in females causes subfertility. Our only bile acid supplementation 
was an acute exposure to CA, while the male animals were exposed over time to a 
0.5% supplementation. There also could be differences in male and female metabolism 
of bile acid. In our studies, female pituitary primary culture was less responsive to CA 
and INT777 than male pituitary primary culture. Additionally, males did not show 
changes in bile acid saturation, or the levels of cholesterol within the bile acid pool 
with puberty, although females did.
42
 Similarly, in rats, females had a larger bile acid 
pool than males during puberty, though it was similar to males at other time points.
41
 
These indicate there is sex specific bile acid regulation, which could explain the 
differences noted between our studies and those of the Volle group.
36–38,60
  
 Due to the multitude of studies displaying alterations in bile signaling through 
puberty and the direct impact of bile duct ligation on reproductive function, we chose 
to investigate the relationship of TGR5 transcript level and puberty.
39–42,61
 
Interestingly, TGR5ko animals showed a delay in puberty, and TGR5 transcript levels 
fluctuated before and after puberty: they increased 3fold from pre-pubertal levels post-
puberty The alterations during puberty could be part of the link between nutrition, 
metabolism and reproduction, since changes in body mass and body composition are 
known to regulate onset of puberty.
62–65
. Signaling in the HPG axis alters during 
puberty as well. GnRH pulsatility increases and estradiol changes from inhibition of 
the pituitary permissive of gonadotropin production.
66,67
 While kisspeptin and KNDY 
neurons have been implicated of the pubertal transition, it is possible that TGR5 and 
bile acid signaling may also contribute.
68
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 Our data identifies a novel regulator of gonadotropin production in the 
pituitary, bile acid receptor TGR5. Reduced reproductive capacity of TGR5ko females 
indicates that TGR5 and bile acids could be used as a modulator of reproductive 
function. This has potential implications for management and treatment of obesity and 
diabetes related infertility. Additionally, TGR5 and bile acid metabolism may be 
implicated in alteration of the onset of puberty.
69–73
 Further studies should focus on the 
mechanisms and clinical implications, along with long term effects of bile acid 
supplementation and the effects on female reproduction.  
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CHAPTER 5 
 
Conclusions and Future Directions 
 
 
 
Introduction 
 
Gonadotropin-releasing hormone (GnRH), released from the median eminence 
of the hypothalamus, is transported directly to the pituitary through the hypophyseal 
portal system.
1
 There, it binds to the GnRH receptor (GnRHR), activating pituitary 
gonadotropes and stimulating the secretion of gonadotropin hormones, follicle 
stimulating hormone (FSH) and luteinizing hormone (LH). These peptide hormones 
are heterodimers, composed of unique β-subunits (LHβ and FSHβ), and a common 
glycoprotein hormone α-subunit (αGSU). 2 The gonadotropins act upon the gonads, 
promoting gametogenesis and steroidogenesis.
3
  
GnRHR is a G-protein coupled receptor (GPCR) that lacks the intracellular C-
terminal tail associated with GPCRs, which renders it resistant to down regulation and 
desensitization.
4–9
 Ligand (GnRH) binding activates a signaling cascade beginning 
with Gαq, and phospholipase C β (PLC). The signaling cascade results in intracellular 
calcium release and extracellular calcium influx.
10–13
 This increase in intracellular 
calcium initiates mitogen activated protein kinase (MAPK) cascade activation.
14–16
 
 The MAPK cascade involves serial phosphorylation of subsequent serine-
threonine kinases.
17–20
 While there are multiple MAPK cascades, the studies in this 
dissertation focus on understanding the role of ERK1/2 signaling in reproduction, 
using transgenic mice. ERK1 knockout (ko) mice have been shown to be viable and 
fertile, but ERK2ko is embryonically lethal.
21–24
 To circumvent this difficulty, we 
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utilized multiple Cre drivers, most notably GRIC (GnRH Receptor IRES Cre), which 
causes Cre expression specifically in cells expressing GnRHR.
25
 Utilizing this mouse 
model, we worked to understand the role of ERK1/2 signaling in the reproductive axis, 
specifically in cells expressing GnRHR. This led us to investigate the role of GnRHR 
and ERK in aging, pregnancy and aspects of metabolism.  
 
ERKs, GnRHR, and gonadotropins in aging 
 The first set of studies described in this thesis focused on understanding and 
describing the deleterious effects of chronic hypogonadotropism on gonadal aging, 
reproductive characteristics and body weight. Our lab, among others, has shown the 
importance of ERK in gonadotropin production and signaling.
26–28
 Utilizing the GRIC 
mouse, we excised ERK2 in pituitary gonadotropes. Our studies revealed a phenotype 
similar to that described by Bliss et al, and displayed the absolute requirement for 
ERK signaling in gonadotropin production and secretion. (Table 1) 
26
 Briefly, at 6 
months of age, the females were infertile, anovulatory, and acyclic, while the males 
displayed mild subfertility. 
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Table 1: Summary of reproductive characterization of ERK deletion using the 
αGSU and GRIC Cre mice 
 
αGSU cre Gric Cre 
Female 
  Estrous cycle Anestrous Prolonged cycle 
Female fertility Infertile  Infertile 
Ovarian histology No CLs No CLs 
LH serum levels NS from control Reduced from controls 
FSH serum levels NS from control Reduced from controls 
Castration response 
Blunted LH response, normal 
FSH response Blunted LH/FSH response 
Response to exogenous 
gonadotropin Ovulation, not paired 
Ovulation followed by 
pregnancy 
Spontaneous copulatory 
plug None 33% 
   Male  
  Male fertility Normal Subfertile 
Castration response NS from control Blunted LH/FSH response 
LH serum levels NS from control NS from control  
FSH serum levels NS from control Trend lower, NS from control 
Testes histology Normal Reduced tubule size 
*NS: No significant changes  
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These mice, with Cre excision of GnRHR associated ERK signaling, are a 
potential model for idiopathic hypogonadotropic-hypogonadism (IHH). To this end, 
we studied changes in the HPG axis in the ERK double knockout (ERKdko) mice over 
time. Reduction of pituitary gonadotrope function resulted in premature gonadal aging 
and profoundly reduced reproductive capacity as they aged. Despite similar 
gonadotrope related transcript levels, at 12 months old, ERKdko females displayed 
altered ovarian histology, including areas of tissue disorganization and acellularity. 
The ERKdko animals were also significantly heavier than control animals, as they 
aged indicating a link between metabolism and loss of reproductive potential. Aged 
(18 month old) ERKdko males displayed evidence of testicular degeneration, 
including deteriorating or degraded tubules, tubule calcification, and giant spermatid 
cells. These animals also had marked reduction in sperm count, and testicular and 
seminal vesicle weight, and the males showed increased body weight at 9 and 12 
months compared to control animals. 
 One of the hypotheses for these phenotypes was alterations in serum peptide 
and steroid hormones. Though we assayed male serum for FSH and testosterone 
levels, serum LH assays are underway. For females, quantifying the steroid hormone 
levels in serum from young and aged females, and peptide hormones in aged animals 
would give us a better understanding of the impact of gonadotrope ERK loss on 
steroidogenesis and whether gonadotropin secretion decreases with age in these 
animals.  
Additionally, characterizing females at more advanced ages would provide 
information on the effects of long term hypogonadotropism, as the phenotype 
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progresses with age in males. . Testes from ERKdko animals did not show a 
histological phenotype until 18 months, but ovaries showed changes at 12 months. 
Ovaries from 18 month old animals may show a more severe phenotype, which would 
elucidate requirements for gonadotropin secretion for maintenance of the HPG axis. 
This effect appears specific to hypogonadotropism, due to the lack of similar 
phenotype in age matched Stra8 ERKdko males. 
 
Loss of ERK signaling in the placenta results in delayed parturition and fetal 
mortality 
 Even more striking than the gonadal degeneration phenotype seen in these 
animals was their inability to maintain a pregnancy and produce viable pups, 
indicating the requirement for ERK signaling throughout pregnancy. Again using the 
GRIC model, we assessed female ERKdko animals’ response to exogenous 
gonadotropin administration. Though they formed CLs in response to a superovulation 
protocol, only one third of treated females became pregnant. Along with poor 
conception rates, ERK signaling seems to be of paramount importance for pregnancy 
termination as well. These animals not only suffered from prolonged gestation and a 
dystocia, but they had absolute fetal mortality.  
 The data reported in this dissertation supports the conclusion that this dramatic 
neonatal mortality phenotype may be due to loss of ERK signaling in GnRHR 
expressing cells in the placenta. The placentas from ERKdko animals showed 
abnormal cystic areas in the decidua and junctional zone, along with other histological 
abnormalities, including decreased vascularization and peri-parturient decidual 
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apoptosis. Placental ERK signaling in decidual cells and in later gestation in 
trophoblasts regulates placental growth and its loss abrogates the normal cascade to 
initiate parturition. ERK signaling is required for normal placentation, and total loss of 
ERK2 signaling results in catastrophic placental failure and embryonic lethality.
29
 Our 
model indicates that even partial loss of ERK signaling can have drastic consequences.  
 Although the studies in this dissertation served to characterize the pregnancy 
and placental phenotype seen in the GRIC mouse, there are several areas for further 
study. Understanding the respective maternal and fetal contributions to the phenotype 
observed in Chapter 3 is a prime area of interest. Recall, in the current studies on 
ERKdko females all the pups died before PN day 3 and the causality of this fetal loss 
remains a gap in our knowledge. Do these neonates die due to ERK loss or insufficient 
maternal care? Performing terminal cesarean sections on ERKdko dams at term, and 
cross-fostering the pups to a surrogate dam would allow us to assess pup viability in 
relation to ERK status in the pups. Staining the placentas from these pups for TUNEL 
would show whether the loss of apoptosis resulted from a delay in parturition initiation 
or loss of signal to initiate placental separation. A more elegant approach would be to 
use embryo transplantation, taking embryos from ERKdko dams and transplanting 
them into Control females, and conversely, embryos from Control dams into ERKdko 
females. We would expect the ERKdko fetuses to grow normally and not exhibit this 
placental phenotype. When performing the reverse experiment (control embryos 
transferred into ERKdko dams), we would expect to recapitulate the prolonged 
gestation phenotype. These studies would allow us to understand the basis of the 
changes in pregnancy, parturition and placentation. We could then use this model 
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system to examine various pharmacological approaches to initiation of parturition to 
rescue the delayed parturition phenotype. For example, supplementing the ERKdko 
animals at e20 with pharmacologic agents known to be involved in parturition, such as 
calcium, oxytocin, dexamethasone, or PGF2α, could help elucidate the mechanism 
behind the dystocia phenotype. These types of studies could have important 
implications regarding how IHH patients may be treated under similar circumstances. 
While these experiments would explain the clinical effects and rescue the phenotype, 
unbiased screening (RNA seq, or proteomics) of the ERKdko and Control animals 
would provide insight into the molecular basis of the phenotype. Comparing these 
results with the RNA seq (Chapter 4) and proteomics previously performed in our lab 
could illuminate additional ERK targets.
30
  
 An additional set of experiments would investigate the endogenous levels and 
effects of hormone supplementation throughout pregnancy. Anecdotally, many of the 
ERKdko mice seem to undergo abortions during the course of gestation. Measuring 
changes in estradiol, progesterone, LH and FSH throughout pregnancy could aid in 
understanding the cause behind these losses. Blunted progesterone upregulation 
throughout pregnancy could contribute to embryonic losses, and is an important 
differential diagnosis for spontaneous abortions. Monitoring the changes in 
gonadotropins throughout gestation in ERKdko animals and comparing them to 
control levels might help identify key time periods of required gonadotropin signaling. 
If these hormones are found to be at deficient levels, supplementation throughout 
pregnancy in ERKdko animals may help rescue the phenotype observed. We 
analyzed placental development, histology, and vascularization at e18.5 and GnRHR 
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expression at e12.5 and e18.5, but performing serial assessments throughout the 
course of gestation would help elucidate the origin of the histological changes seen at 
e18.5, and the changes in GnRHR localization between e12.5 and e18.5. Assessing 
fetal development (weight, crown-rump length, fetal resorption sites) and placentation 
(histology, GnRHR expression, ERK loss) in ERKdko dams at additional time points 
would provide increased clarity on the mechanisms underlying the phenotype. 
Identifying the day of Cre activation in the placenta could help elucidate specific cell 
types affected and identify the functional role of ERK and GnRHR in placental 
development. Historically, it was believed women with IHH suffer from infertility due 
to hormonal abnormalities.
31
 This model elucidates another possible avenue to 
consider, especially in patients with GnRHR mutations.  
 
Pituitary bile acid receptor, TGR5, modulates reproduction  
 Although our previous studies had illuminated novel roles of ERK signaling in 
aging and placental formation and function, they focused on the clinical outcomes and 
physiologic importance of the intact signaling cascade. In contrast, our third set of 
studies focused on a known location and role of ERK signaling in pituitary 
gonadotropes and identification of different gene transcripts regulated by GnRH and 
ERK. 
Again, using the GRIC mice, we conducted unbiased screens (RNA 
sequencing) to identify ERK-dependent targets downstream of GnRH signaling in the 
pituitary. These screens revealed a multitude of targets, including the GPCR bile acid 
receptor, TGR5. We confirmed TGR5’s presence in the pituitary, along with 
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upregulation in response to GnRH and negation of this effect in the absence of ERK. 
After confirming both the localization of TGR5 and its response to GnRH, we treated 
primary pituitary culture cells with a TGR5 agonist. Amazingly, this treatment 
resulted in LH secretion. Subsequently, female mice treated with PMSG and a TGR5 
agonist resulted in ovulation and CL formation in a manner consistent with a 
superovulation paradigm. TGR5ko females were found to be subfertile and displayed 
delayed onset of puberty. Together, these data indicate TGR5 plays a functional role in 
the HPG axis, modulating fertility and onset of puberty.  
 One caveat of the studies described above is the loss of TGR5 is not tissue-
specific, and the phenotypes observed could be due to TGR5 expression and signaling 
in multiple parts of the HPG axis. To this end, we have procured a TGR5floxed 
(TGR5
f/f
) mouse, and plan to cross these animals with several Cre lines already 
established in our lab to provide tissue-specific knockouts. These include GRIC Cre 
(pituitary gonadotropes), Kisspeptin Cre (hypothalamus), Stra8 Cre (testis) and ZP3 
Cre (ovary). Characterization of the progeny of these crosses will allow analyses of 
the isolated effect of loss of TGR5/ERK signaling in various tissues within the 
reproductive axis and more carefully dissect the role of bile acid signaling on 
reproductive potential.  
 Delay of puberty by 4 days in TGR5ko animals was a significant finding. 
Hypothesizing that bile acids and TGR5 signaling helps modulate the timing of 
puberty, we plan to feed prepubertal control females a TGR5-specific agonist INT777 
supplemented diet. Since this would constitutively activate TGR5 signaling in various 
tissues including within the reproductive axis, we hope it may cause puberty to occur 
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earlier with TGR5ko females as a negative control. Measuring LH and FSH after 
INT777 supplementation would allow quantification of changes in gonadotropin 
production and secretion by TGR5. Additionally, adding more time points to the study 
assessing TGR5 transcript levels during the pubertal transition might help elucidated 
the precise changes in timing of bile acid and TGR5 signaling during puberty. 
 Despite the plethora of data indicating TGR5 is functional in the gonadotrope, 
we have not yet localized this receptor within the pituitary. We are collaborating with 
the IHC core at Cornell to develop IF conditions for colocalization of TGR5 and LH in 
pituitary gonadotropes and potential other endocrine cell lineages.  
 TGR5 is preferentially activated by hydrophobic bile acids, compared to 
hydrophillic. Treating either αT-31 cells or primary pituitary cells with bile acids of 
different hydrophobicities and assessing TGR5 activation through CREB 
phosphorylation or LH secretion would further our understanding of the mechanisms 
behind this phenomenon. If TGR5 agonist-induced gonadotropin secretion occurs 
independently from GnRHR signaling, cholic acid or other TGR5 agonists could be an 
integral part of a fertility treatment regimen. To assess this, we would treat primary 
cells with antide, a GNRH antagonist, and a TGR5 agonist, to understand if it is 
independent of GnRHR signaling.  
 The three data chapters in this dissertation describe three exciting and novel 
roles for ERK2 signaling in the context of GnRH signaling. These roles confirm the 
diversity of ERK expression and the requirement for ERK signaling in routine 
function and normal tissue proliferation. Investigating the role of ERK signaling in a 
variety of tissues and cell types the HPG axis provides insight into GnRH signaling, 
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the role of gonadotropins in maintaining gonadal health over time, and GnRHR’s role 
in the placenta. Additionally, we have identified a novel target of GnRH signaling, 
TGR5, which shows promise to be a link between nutrition, metabolism, reproduction 
and puberty.  
 Although the field of reproduction has been well studied in many aspects, the 
studies included in this dissertation show that ERK signaling has far wider 
implications than those already described in the literature. All three manuscripts 
describe novel roles of GnRH associated ERK signaling with important clinical 
implications. Understanding the role of hypogonadotropism in gonadal aging and the 
role of ERK in placentation could help improve fertility for those with IHH, 
Kallmanns syndrome, or other GnRHR associated mutations. Identification of TGR5 
as a key regulator of reproduction opens new avenues into understanding the 
interconnected processes of reproduction and metabolism, especially in the context of 
puberty. It is possible that the alterations in body weight in the ERKdko animals as the 
aged (Chapter 2), could be related to reduced TGR5 expression and function in the 
pituitary gonadotropes (Chapter 4). Identifying the mechanisms such as these, which 
control the basic regulation of reproduction, hold promise for improving clinical 
fertility and contraceptive treatments.  
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Figure 1: Loss of ERK1/2 signaling in the reproductive axis has wide ranging and 
disastrous consequences for reproductive potential 
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